{"meta":{"query_hash":"9068ed2785af","filters":{"venue":"npj Breast Cancer"},"cohort_total":84,"direct_labels_cover":0,"predictions_cover":84,"exported":84,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9068ed2785af","api":"https://metacan.xera.ac/api/v1/cohort?venue=npj+Breast+Cancer"},"results":[{"id":"W2254049207","doi":"10.1038/npjbcancer.2015.9","title":"Preventing breast cancer now by acting on what we already know","year":2015,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Foundation for Barnes-Jewish Hospital; Breast Cancer Research Foundation","keywords":"Menarche; Breast cancer; Demography; Menopause; Medicine; Incidence (geometry); Quarter (Canadian coin); Cancer; Gynecology; Gerontology; Internal medicine; History","score_opus":0.015822233236680673,"score_gpt":0.3270193469797726,"score_spread":0.3111971137430919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254049207","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063772284,0.061743196,0.0001950976,0.108847745,0.8250191,0.000022153916,0.000043426342,0.00008345593,0.0039820066],"genre_scores_gemma":[0.0004923693,0.0590902,0.0002690103,0.0831468,0.84634876,0.000024382884,0.00003569088,0.000033369048,0.010559425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693596,0.00067777693,0.000393903,0.00032528362,0.0014827556,0.00018443717],"domain_scores_gemma":[0.9896108,0.0050541502,0.0005342626,0.0004180737,0.0029712196,0.0014114955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040369695,0.0029043548,0.002515587,0.0017161113,0.0020499649,0.005060404,0.0021033748,0.009321613,0.0115014035],"category_scores_gemma":[0.014189025,0.0007663742,0.0017674993,0.0010273815,0.0026642492,0.005118056,0.0017610062,0.028723804,0.011422075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002949835,0.000036560425,0.00007306881,0.0006104254,0.000028140194,0.00010103614,0.000045955152,0.000032494354,0.00010271976,0.00079843163,0.96756625,0.030575586],"study_design_scores_gemma":[0.00001865255,0.00002306408,0.00020305114,0.00052395003,0.000029168605,0.0001914113,0.000053892498,0.000030706313,0.000041977248,0.0011755964,0.9976973,0.000011221363],"about_ca_topic_score_codex":0.001997226,"about_ca_topic_score_gemma":0.0044996804,"teacher_disagreement_score":0.0115014035,"about_ca_system_score_codex":0.002112185,"about_ca_system_score_gemma":0.002426173,"threshold_uncertainty_score":0.03847605},"labels":[],"label_agreement":null},{"id":"W2337607123","doi":"10.1038/npjbcancer.2016.9","title":"TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; National Cancer Institute; Conquer Cancer Foundation; National Institutes of Health; Geoffrey Beene Cancer Research Center; Breast Cancer Research Foundation","keywords":"Cytotoxicity; Cytotoxic T cell; Breast cancer; Tumor necrosis factor alpha; Medicine; Cancer; Immunology; Cancer research; Internal medicine; Biology; In vitro","score_opus":0.010330702889234253,"score_gpt":0.24132856272135642,"score_spread":0.23099785983212218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337607123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942517,0.0037642943,0.0002814174,0.00020086195,0.000027219352,0.000021891938,0.00044009121,0.000015869642,0.0009966999],"genre_scores_gemma":[0.99831736,0.000638135,0.00019568333,0.00008052316,0.000028253513,0.000012577228,0.0003903442,0.0000025766847,0.0003346242],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998037,0.00005001595,0.000025021394,0.00004221569,0.000039783245,0.00003920862],"domain_scores_gemma":[0.99968576,0.000049748993,0.00016401308,0.000014935832,0.00004293341,0.000042707954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016666263,0.00016706868,0.00024123715,0.0002360676,0.00018003109,0.00043159572,0.000103954684,0.00019562582,0.0014347142],"category_scores_gemma":[0.0007997071,0.00008152127,0.00015631752,0.0002910369,0.00009234977,0.00015297254,0.00017775684,0.00028628143,0.00027055343],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029205375,0.00011557124,0.8913196,0.00024594748,0.000087816545,0.001247339,0.0002320366,0.00019593597,0.06482033,0.00012846633,0.0013968841,0.037289474],"study_design_scores_gemma":[0.00007044726,0.000709172,0.96663475,0.00007791171,0.00016495184,0.0071861385,0.00049740623,0.00072123,0.016796127,0.00024570205,0.0068839844,0.000012207891],"about_ca_topic_score_codex":0.0005794413,"about_ca_topic_score_gemma":0.0005812927,"teacher_disagreement_score":0.0014347142,"about_ca_system_score_codex":0.00028521297,"about_ca_system_score_gemma":0.00014854188,"threshold_uncertainty_score":0.0047996044},"labels":[],"label_agreement":null},{"id":"W2346853311","doi":"10.1038/npjbcancer.2016.7","title":"DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Breast cancer; DNA methylation; Biology; Cancer; Epigenetics; genomic DNA; Gene; microRNA; Cancer research; Gene expression; Genetics","score_opus":0.008827057926447526,"score_gpt":0.24618278996116574,"score_spread":0.23735573203471821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346853311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9617272,0.0038886592,0.0010637477,0.0002559733,0.00001825837,0.00003498385,0.031202719,0.00009793402,0.0017105719],"genre_scores_gemma":[0.9694518,0.0017841355,0.0012351964,0.00013018353,0.000016880636,0.00007535091,0.026253438,0.00003942682,0.0010136461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997632,0.000028849077,0.000023070306,0.000090098576,0.00006333027,0.000031497933],"domain_scores_gemma":[0.99948406,0.0001269447,0.00013895183,0.00008565801,0.00009432721,0.00007003308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029192647,0.00012243396,0.0004582249,0.0010749677,0.00029295165,0.00046073785,0.00027390677,0.00019587106,0.0010028377],"category_scores_gemma":[0.0009828181,0.00012141782,0.00033153582,0.0021090545,0.0001243351,0.00014541097,0.0004522596,0.00020692163,0.0001755436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014272014,0.0000684922,0.9272699,0.0005755586,0.0010563985,0.000546595,0.00030981706,0.0005269834,0.019968444,0.00039262132,0.0064678504,0.04139008],"study_design_scores_gemma":[0.000019675828,0.000041345345,0.98920876,0.000012770575,0.0003818714,0.0007851635,0.00007326411,0.00040153065,0.0018615274,0.00011018824,0.0070941728,0.000009835489],"about_ca_topic_score_codex":0.008938082,"about_ca_topic_score_gemma":0.016409935,"teacher_disagreement_score":0.008938082,"about_ca_system_score_codex":0.00037809793,"about_ca_system_score_gemma":0.00045237105,"threshold_uncertainty_score":0.017772079},"labels":[],"label_agreement":null},{"id":"W2407306171","doi":"10.1038/npjbcancer.2016.14","title":"Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; University of Alberta; Ontario Institute for Cancer Research; Juravinski Hospital; McMaster University; Health Sciences Centre; Mount Sinai Hospital; University of British Columbia","funders":"Cure Brain Cancer Foundation; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Ontario; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Intraclass correlation; External quality assessment; Reproducibility; Medicine; Nuclear proliferation; Protocol (science); Breast cancer; Core biopsy; Confidence interval; Biomarker; Multicenter study; Nuclear medicine; Pathology; Statistics; Internal medicine; Cancer; Mathematics; Randomized controlled trial","score_opus":0.024729871601926665,"score_gpt":0.3991916576170507,"score_spread":0.37446178601512403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407306171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39994097,0.0030493147,0.31074044,0.0010633065,0.0008801155,0.2692045,0.0037921588,0.000994318,0.0103349835],"genre_scores_gemma":[0.40544224,0.0015435708,0.38868093,0.0010956794,0.00030791172,0.18160598,0.017500013,0.00080612,0.003017482],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.845462,0.107759774,0.009998639,0.009858919,0.024075845,0.0028447893],"domain_scores_gemma":[0.82650506,0.0265747,0.018721519,0.043764412,0.07938319,0.0050511863],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25058052,0.0031732635,0.0020900469,0.0035191872,0.0038303088,0.0029033346,0.0059063327,0.0035249288,0.002168932],"category_scores_gemma":[0.119722694,0.0014988041,0.0031540303,0.0045881174,0.004740747,0.0018922637,0.0062746815,0.003159683,0.0018237602],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042345345,0.05365336,0.29308578,0.0073471353,0.006174792,0.00083296554,0.022930121,0.019570297,0.13763177,0.011804836,0.022939421,0.3816842],"study_design_scores_gemma":[0.028790202,0.1572703,0.55706406,0.003026018,0.0044300407,0.0013695038,0.006584369,0.02895047,0.11043074,0.005375789,0.09598087,0.0007276637],"about_ca_topic_score_codex":0.0058391606,"about_ca_topic_score_gemma":0.0042646932,"teacher_disagreement_score":0.25058052,"about_ca_system_score_codex":0.0042918725,"about_ca_system_score_gemma":0.018823978,"threshold_uncertainty_score":0.92416763},"labels":[],"label_agreement":null},{"id":"W2470412971","doi":"10.1038/npjbcancer.2016.22","title":"The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Oncology; Medicine; Internal medicine; Population; Cancer; Cancer research","score_opus":0.009950373896513452,"score_gpt":0.28530443092892915,"score_spread":0.2753540570324157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470412971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906033,0.0002282838,0.0002460313,0.000026781978,0.000002351519,0.000026942138,0.00025640486,0.0000039811084,0.00014886861],"genre_scores_gemma":[0.9984749,0.00009466034,0.0002971613,0.000058717058,0.0000060456073,0.000036964677,0.00081910176,0.0000031838856,0.00020930814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969256,0.00012451745,0.000019442768,0.00006182359,0.00005806537,0.000043623288],"domain_scores_gemma":[0.9996896,0.00006466963,0.00008709606,0.000050668845,0.00005499642,0.000053043605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010706995,0.00015150668,0.00039995916,0.00021084344,0.00021689679,0.0004943181,0.00014410821,0.00018871503,0.00047773114],"category_scores_gemma":[0.0007855016,0.000115133225,0.00021761995,0.0003567269,0.000139561,0.00017805539,0.00020700786,0.0002970545,0.00014489208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075950697,0.0008379688,0.92393357,0.00003771863,0.00025861472,0.00008685231,0.00012711974,0.00069241563,0.03891369,0.00007443296,0.00061451545,0.026828097],"study_design_scores_gemma":[0.00021708531,0.003956625,0.9888264,0.000007196186,0.00017203038,0.00029194393,0.00009893959,0.0010851916,0.0038848184,0.000087757086,0.0013641696,0.000007917753],"about_ca_topic_score_codex":0.0005740473,"about_ca_topic_score_gemma":0.0008172138,"teacher_disagreement_score":0.0010706995,"about_ca_system_score_codex":0.00024575135,"about_ca_system_score_gemma":0.00035587873,"threshold_uncertainty_score":0.0056624413},"labels":[],"label_agreement":null},{"id":"W2544829712","doi":"10.1038/npjbcancer.2015.14","title":"αB-crystallin expression in breast cancer is associated with brain metastasis","year":2015,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Breast cancer; Brain metastasis; Immunohistochemistry; Oncology; Metastasis; Medicine; Proportional hazards model; Estrogen receptor; Cancer research; Internal medicine; Tissue microarray; Cancer; Pathology","score_opus":0.022812973232451246,"score_gpt":0.3123760208703252,"score_spread":0.28956304763787394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544829712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975406,0.00097412115,0.00018868655,0.000090985646,0.0000056074177,0.0000046670807,0.00053596264,0.000014589782,0.00064481335],"genre_scores_gemma":[0.99885225,0.00023082821,0.00011098298,0.00001551617,0.000007038235,0.0000041013473,0.0005109493,0.0000033856886,0.00026489657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985754,0.000020359472,0.000009794814,0.000037365648,0.000047288326,0.0000276751],"domain_scores_gemma":[0.9992349,0.00011640577,0.00034539265,0.00003990268,0.00013309179,0.00013027382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020048145,0.00016298657,0.0002581159,0.00047293422,0.00021848628,0.00032284035,0.0001898669,0.00021312007,0.002142665],"category_scores_gemma":[0.00073370605,0.00009146015,0.00016602976,0.00082176825,0.00022804024,0.000088236506,0.00019970722,0.00032945597,0.0002469968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008432871,0.000032538086,0.9735021,0.00008235924,0.00010612285,0.0004017873,0.000058121917,0.00019414366,0.017698972,0.000039174607,0.0007145359,0.0063269064],"study_design_scores_gemma":[0.0000035585683,0.000024172914,0.99819154,0.000005450384,0.000025271876,0.0004345993,0.000034213754,0.00022560179,0.0007903821,0.00003483025,0.00022833492,0.0000019157753],"about_ca_topic_score_codex":0.007774119,"about_ca_topic_score_gemma":0.007868398,"teacher_disagreement_score":0.007774119,"about_ca_system_score_codex":0.0004250363,"about_ca_system_score_gemma":0.00033768296,"threshold_uncertainty_score":0.015457749},"labels":[],"label_agreement":null},{"id":"W2587895918","doi":"10.1038/s41523-016-0003-5","title":"Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Cancer Research UK; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Oncology; Medicine; Breast cancer; Internal medicine; Gene signature; Druggability; Tamoxifen; Cohort; Hazard ratio; Cancer; Bioinformatics; Gene; Biology; Gene expression","score_opus":0.010883199883549792,"score_gpt":0.29636171687394103,"score_spread":0.28547851699039123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587895918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801481,0.0076109343,0.007863938,0.0015981946,0.000045653327,0.00008205515,0.0008575855,0.0001513971,0.0016422132],"genre_scores_gemma":[0.9938507,0.0010793516,0.00399709,0.00025895977,0.000025201625,0.000017249527,0.00045616215,0.000007875057,0.00030735056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978954,0.000072467985,0.000014796974,0.000034645767,0.000057500194,0.000031131287],"domain_scores_gemma":[0.9995467,0.00015181786,0.00016362347,0.000036734527,0.000055460237,0.000045653465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000788157,0.0003158031,0.0005514611,0.0007120876,0.0001541423,0.000807132,0.00022106855,0.00026659173,0.0009263058],"category_scores_gemma":[0.0011655643,0.00012257975,0.00033099452,0.0005918869,0.00022373014,0.00029327246,0.00034406062,0.0004980025,0.00029179928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021306786,0.00042059104,0.56606144,0.0005683633,0.00047963063,0.0003638014,0.0001220856,0.0074052555,0.2197925,0.001677605,0.0032435441,0.19773453],"study_design_scores_gemma":[0.00023795414,0.0025909464,0.86076564,0.00021125119,0.0008570883,0.0011381555,0.00036592458,0.03530611,0.0755104,0.010277079,0.012680168,0.000059291033],"about_ca_topic_score_codex":0.0004790417,"about_ca_topic_score_gemma":0.00090905296,"teacher_disagreement_score":0.0009263058,"about_ca_system_score_codex":0.00039172726,"about_ca_system_score_gemma":0.00041334587,"threshold_uncertainty_score":0.0041682124},"labels":[],"label_agreement":null},{"id":"W2604847249","doi":"10.1038/s41523-017-0013-y","title":"Breast cancers are rare diseases—and must be treated as such","year":2017,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer","score_opus":0.006888642626517182,"score_gpt":0.27208320482393233,"score_spread":0.26519456219741516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604847249","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051364903,0.06275639,0.00036352364,0.09632062,0.83750904,0.000016979006,0.000044517445,0.00008402368,0.0028535705],"genre_scores_gemma":[0.0006454373,0.04988144,0.00029828813,0.05310994,0.8899802,0.000017318725,0.000037451926,0.00003871588,0.00599118],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666023,0.0007553656,0.00045456362,0.00041793016,0.0015415219,0.00017036808],"domain_scores_gemma":[0.98261964,0.010709021,0.00080603187,0.00063332927,0.0038517602,0.0013802606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047474094,0.0016425445,0.0021721667,0.0012862834,0.0016212512,0.0049870494,0.0025523978,0.0092615625,0.0068791467],"category_scores_gemma":[0.016958667,0.00061560766,0.001067675,0.00079206045,0.0039398805,0.0049051074,0.001756524,0.02563639,0.0075015654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024653367,0.000013952047,0.000038133043,0.0004547076,0.000016132693,0.00019458974,0.000039196595,0.000032779793,0.00008415244,0.0024681834,0.96365774,0.032975737],"study_design_scores_gemma":[0.000008380862,0.000010889169,0.00007185179,0.00026725145,0.000009069065,0.00029365462,0.000025721047,0.000023507397,0.000032604217,0.0017476097,0.99750274,0.000006822207],"about_ca_topic_score_codex":0.0010274843,"about_ca_topic_score_gemma":0.0021359925,"teacher_disagreement_score":0.0092615625,"about_ca_system_score_codex":0.0018770777,"about_ca_system_score_gemma":0.00255233,"threshold_uncertainty_score":0.025106966},"labels":[],"label_agreement":null},{"id":"W2623464423","doi":"10.1038/s41523-017-0024-8","title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Oxnard Foundation; Pennsylvania Department of Health; Stop Cancer; Avon Foundation for Women; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; CHEK2; PALB2; Odds ratio; Oncology; Medicine; Germline mutation; Cancer; Genetics; Internal medicine; Mutation; Biology; Gene","score_opus":0.008631985747489999,"score_gpt":0.2878752612757638,"score_spread":0.27924327552827377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623464423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847597,0.0004895621,0.0005207986,0.00004257949,0.000005864082,0.0000037050177,0.000095165255,0.000009575678,0.0003568857],"genre_scores_gemma":[0.9996402,0.00007291495,0.00017616591,0.00000938283,0.0000063154553,0.0000015478253,0.000049497947,0.000002381852,0.00004148942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911886,0.00029600167,0.00007947366,0.00023064422,0.00019876404,0.00007625317],"domain_scores_gemma":[0.9976609,0.0010436611,0.0007283473,0.00025976473,0.00017109691,0.00013618742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011340528,0.0003441374,0.00026073997,0.0013988414,0.00035482735,0.0004997446,0.00034313134,0.0004276657,0.0018449383],"category_scores_gemma":[0.004449761,0.00022708667,0.00031482222,0.00093226595,0.00044324764,0.00018644732,0.00036555884,0.00039705733,0.00012357238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018395865,0.000017996574,0.98982316,0.000014294498,0.00024180149,0.00048021515,0.00005724145,0.0002034321,0.004497621,0.00011109007,0.00008198607,0.0042871255],"study_design_scores_gemma":[0.000009710713,0.00003569207,0.9949511,0.000010839604,0.00011546135,0.0022602368,0.0000559937,0.0011242055,0.0009496722,0.00029337397,0.00018852457,0.000005271729],"about_ca_topic_score_codex":0.0019616913,"about_ca_topic_score_gemma":0.0016684415,"teacher_disagreement_score":0.0019616913,"about_ca_system_score_codex":0.00017680835,"about_ca_system_score_gemma":0.00012403396,"threshold_uncertainty_score":0.0061719418},"labels":[],"label_agreement":null},{"id":"W2753529942","doi":"10.1038/s41523-017-0040-8","title":"Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design","year":2017,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Victoria; University of British Columbia","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Harvard University; American College of Radiology Imaging Network; Breast Cancer Research Foundation; Susan G. Komen for the Cure","keywords":"Medicine; Weight loss; Breast cancer; Overweight; Cancer; Randomized controlled trial; Body mass index; Weight change; Internal medicine; Obesity; Physical therapy; Oncology","score_opus":0.08614657863996368,"score_gpt":0.4208260353502067,"score_spread":0.334679456710243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753529942","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8619433,0.007940346,0.0040037315,0.003668329,0.004988292,0.103166945,0.006864922,0.00040383515,0.0070202737],"genre_scores_gemma":[0.8139575,0.0039639394,0.0076308907,0.005150112,0.0019025282,0.1523884,0.0031034902,0.00007543333,0.011827745],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99714124,0.001959517,0.00014959984,0.00034215537,0.00015192511,0.0002555187],"domain_scores_gemma":[0.99691796,0.0011000326,0.00069599133,0.00027460838,0.0002263842,0.00078506174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062106852,0.0030382122,0.0045834985,0.00065417826,0.00076782046,0.0014946259,0.0013127351,0.0036133102,0.013229524],"category_scores_gemma":[0.00615454,0.00090331765,0.0032230187,0.0008281916,0.001685622,0.0015293516,0.00088293274,0.0042552454,0.0018319958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9888574,0.005179673,0.00026063377,0.000520881,0.000578742,0.000017884651,0.000015898657,0.00017994049,0.00048244002,0.00009914351,0.000541307,0.0032659173],"study_design_scores_gemma":[0.9727352,0.026028525,0.00035241485,0.000027409738,0.0002488217,0.0000060094176,0.0000071411323,0.00015164382,0.00006732947,0.00011012298,0.00025940614,0.000005897278],"about_ca_topic_score_codex":0.0011617971,"about_ca_topic_score_gemma":0.001904148,"teacher_disagreement_score":0.013229524,"about_ca_system_score_codex":0.0009595732,"about_ca_system_score_gemma":0.002383305,"threshold_uncertainty_score":0.044257164},"labels":[],"label_agreement":null},{"id":"W2768048855","doi":"10.1038/s41523-017-0046-2","title":"Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","year":2017,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Oncology; Cancer; Gene; Genetics; Medicine; Biology; Internal medicine","score_opus":0.008589174223133095,"score_gpt":0.2782639418366811,"score_spread":0.26967476761354797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768048855","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023875693,0.0009207845,0.0006864563,0.04063217,0.95483613,0.000012750051,0.0008261939,0.00019721007,0.0016496049],"genre_scores_gemma":[0.03650658,0.016687062,0.0107088415,0.10873724,0.53313065,0.00020383007,0.005703046,0.0026852957,0.28563744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958851,0.00062386383,0.0006451857,0.00063366594,0.0018508431,0.0003613413],"domain_scores_gemma":[0.97606575,0.007818085,0.0010289785,0.0012211652,0.01287324,0.000992699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003464999,0.0017661923,0.0013472127,0.0025458534,0.0022276668,0.0026339216,0.002896639,0.004563427,0.039357048],"category_scores_gemma":[0.048464153,0.0008087345,0.0014788742,0.0016133739,0.0014282138,0.0015501243,0.0015941731,0.010369203,0.018609798],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000417499,0.0000065187546,0.00014015313,0.00010444779,0.000018477407,0.00049130974,0.00003692742,0.0000487402,0.00008624988,0.0006950398,0.9917282,0.006602337],"study_design_scores_gemma":[0.00006567085,0.000023212226,0.0010782208,0.00054042303,0.00008079172,0.003037889,0.00011543832,0.0003366254,0.0007753386,0.0020807,0.99180484,0.000060766328],"about_ca_topic_score_codex":0.011371241,"about_ca_topic_score_gemma":0.015688363,"teacher_disagreement_score":0.039357048,"about_ca_system_score_codex":0.0023852366,"about_ca_system_score_gemma":0.003940974,"threshold_uncertainty_score":0.13166243},"labels":[],"label_agreement":null},{"id":"W2769275606","doi":"10.1038/s41523-017-0049-z","title":"Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto","funders":"National Institute for Health and Care Research; Breast Cancer Research Foundation","keywords":"Breast cancer; Medicine; Internal medicine; Oestrogen receptor; Aromatase; Estrogen; Endocrinology; Progesterone receptor; Mastectomy; Cancer; Estrogen receptor","score_opus":0.004951322554612665,"score_gpt":0.2521952689948242,"score_spread":0.24724394644021153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769275606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990528,0.00041565468,0.000028547878,0.000020882848,0.0000032009189,0.000004402691,0.0002571606,0.000002003955,0.0002153283],"genre_scores_gemma":[0.9987447,0.00023062823,0.00004372143,0.000020291849,0.0000022308425,0.0000062940753,0.0002917525,0.0000013074248,0.00065893825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99995565,0.0000051230654,0.0000021240057,0.000012964639,0.0000080193,0.000016161657],"domain_scores_gemma":[0.9999331,0.000013786215,0.000020861977,0.000003710927,0.000014526997,0.000014003798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009029296,0.00009253418,0.0001924852,0.0002592581,0.0001759889,0.00023458204,0.00009251689,0.00014614686,0.0015618852],"category_scores_gemma":[0.00017455715,0.00010846683,0.00013972145,0.0003302925,0.00014703374,0.000057248923,0.00010116321,0.0001427405,0.00017261419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016143281,0.000062209554,0.9267555,0.000121874065,0.0000610268,0.0015179331,0.0006161746,0.00009918653,0.06129746,0.000035655667,0.0002249134,0.007593789],"study_design_scores_gemma":[0.0000037185748,0.00010362088,0.9973852,0.0000035993057,0.00001318563,0.00044277287,0.0003292854,0.00005539659,0.00130726,0.000008637655,0.00034589277,0.0000014701014],"about_ca_topic_score_codex":0.010356998,"about_ca_topic_score_gemma":0.0086556515,"teacher_disagreement_score":0.010356998,"about_ca_system_score_codex":0.00029470696,"about_ca_system_score_gemma":0.00014083312,"threshold_uncertainty_score":0.020593405},"labels":[],"label_agreement":null},{"id":"W2793956875","doi":"10.1038/s41523-018-0056-8","title":"Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort","year":2018,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; Pathological Society of Great Britain and Ireland; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Nottingham Prognostic Index; Pathology; Hormone receptor; Lymph node; Cohort; Cancer; Biology","score_opus":0.013992167010253971,"score_gpt":0.2823321541672078,"score_spread":0.26833998715695384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793956875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978042,0.00021131872,0.00016714774,0.000033672786,0.000004670981,0.0000059246813,0.0012773942,0.000012032756,0.00048359577],"genre_scores_gemma":[0.99643695,0.000093137285,0.00019644099,0.000019863463,0.000007919713,0.000010387635,0.0030402506,0.0000124315175,0.00018273905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995552,0.00007073348,0.000035234956,0.00014798537,0.0001238005,0.00006697],"domain_scores_gemma":[0.9989372,0.00011974321,0.0004269024,0.00017930163,0.00016019776,0.00017664408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062016305,0.00020697253,0.00034279097,0.0012729119,0.000356163,0.00077457645,0.00042298704,0.00027466775,0.0016632567],"category_scores_gemma":[0.0017881553,0.0001894506,0.0003329285,0.0015389287,0.0002871934,0.00022427668,0.00081847934,0.00028881346,0.00022255362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021861414,0.000005656915,0.99507254,0.00001424096,0.000108708424,0.00014245829,0.000082345054,0.00011541455,0.0023388665,0.000055894674,0.0003646684,0.0014806469],"study_design_scores_gemma":[0.0000036055353,0.000019257352,0.9988532,0.0000047130916,0.000028053531,0.00040364373,0.00007231952,0.00014458256,0.00016268123,0.000027254515,0.00027721663,0.0000034976754],"about_ca_topic_score_codex":0.006042574,"about_ca_topic_score_gemma":0.011457623,"teacher_disagreement_score":0.006042574,"about_ca_system_score_codex":0.00029677936,"about_ca_system_score_gemma":0.00029058332,"threshold_uncertainty_score":0.012014806},"labels":[],"label_agreement":null},{"id":"W2947470150","doi":"10.1038/s41523-019-0111-0","title":"SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Berlin Institute of Health; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Internal medicine; Oncology; Cancer; Targeted therapy; Endocrine system; Hormone; Bioinformatics; Cancer research; Biology","score_opus":0.03199847053610999,"score_gpt":0.3266311783684151,"score_spread":0.2946327078323051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947470150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282247,0.00049924076,0.0048715756,0.000088180066,0.000012412296,0.000022600214,0.0010796391,0.00009461315,0.0005092583],"genre_scores_gemma":[0.9959853,0.000062187806,0.0029665597,0.000045138688,0.000017640996,0.000020617079,0.000657995,0.000012610757,0.00023174845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993857,0.00018652345,0.00004905433,0.00016998759,0.00016159001,0.00004716173],"domain_scores_gemma":[0.9984097,0.0007230796,0.0005054588,0.00011382519,0.00012679299,0.00012115229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012996397,0.00038336412,0.0004319151,0.0006795313,0.000120009725,0.00047265054,0.00024194039,0.00034762674,0.0014501329],"category_scores_gemma":[0.0026543771,0.00014426289,0.0003858399,0.0003542759,0.00025578076,0.00022703297,0.00030748238,0.0005277037,0.00031596364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021645336,0.00010693499,0.9077742,0.00006401544,0.00031225677,0.00014505607,0.000040959134,0.0039703823,0.061949123,0.000108414584,0.0005177671,0.022846427],"study_design_scores_gemma":[0.00007057837,0.0011207212,0.93693787,0.0000139583535,0.00028391645,0.0012919453,0.000079781435,0.02839121,0.030068232,0.00046484935,0.0012423878,0.000034697092],"about_ca_topic_score_codex":0.00031869486,"about_ca_topic_score_gemma":0.00043489574,"teacher_disagreement_score":0.0014501329,"about_ca_system_score_codex":0.00021583456,"about_ca_system_score_gemma":0.00014278201,"threshold_uncertainty_score":0.0068731904},"labels":[],"label_agreement":null},{"id":"W2953595023","doi":"10.1038/s41523-019-0113-y","title":"LobSig is a multigene predictor of outcome in invasive lobular carcinoma","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Metro North Hospital and Health Service; Cancer Institute NSW; National Breast Cancer Foundation; Cancer Research UK","keywords":"Nottingham Prognostic Index; Invasive lobular carcinoma; Oncology; Internal medicine; Medicine; Proportional hazards model; Breast cancer; Estrogen receptor; Gene expression profiling; Bioinformatics; Cancer; Gene; Biology; Gene expression; Genetics; Invasive ductal carcinoma","score_opus":0.011775906360530797,"score_gpt":0.2577401540726026,"score_spread":0.2459642477120718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953595023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666625,0.0007303241,0.000700548,0.00010075492,0.000010586083,0.0000060286857,0.001293609,0.000036613896,0.00045526723],"genre_scores_gemma":[0.99847513,0.00008892646,0.00026201553,0.000021563386,0.000008410636,0.0000063235257,0.0009413921,0.0000061846695,0.00019005728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998186,0.000047068723,0.000012585887,0.00005506661,0.000032083728,0.000034526547],"domain_scores_gemma":[0.9992742,0.00028303376,0.00017827463,0.00008242788,0.000059896232,0.00012212958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000637611,0.0003949687,0.00040137503,0.00087696675,0.0002923601,0.0006761521,0.0002741218,0.00034621975,0.0023590545],"category_scores_gemma":[0.0011650504,0.00012279875,0.00065373234,0.0011297986,0.00022359558,0.00031440798,0.0006564958,0.0003939547,0.00028329802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005978315,0.000026599266,0.989356,0.000044192242,0.00030614063,0.00011925228,0.000026347154,0.0006032615,0.0037280063,0.00005165207,0.0002825819,0.0048581115],"study_design_scores_gemma":[0.000019481155,0.00016988388,0.991392,0.00001808871,0.00050544157,0.00043570934,0.0001225079,0.004399837,0.0018296525,0.00038920718,0.00070753705,0.000010631776],"about_ca_topic_score_codex":0.0012844965,"about_ca_topic_score_gemma":0.0018750179,"teacher_disagreement_score":0.0023590545,"about_ca_system_score_codex":0.00030018104,"about_ca_system_score_gemma":0.00025030153,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2967367406","doi":"10.1038/s41523-019-0115-9","title":"Homologous recombination DNA repair defects in PALB2-associated breast cancers","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill Genome Centre; Jewish General Hospital","funders":"National Cancer Institute; Medical Research Council; National Health and Medical Research Council; Ministerstvo Zdravotnictví Ceské Republiky; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cycle for Survival; National Breast Cancer Foundation; National Institute for Health and Care Research; China Scholarship Council; Susan G. Komen; Univerzita Karlova v Praze; Ministry of Higher Education, Malaysia; NIHR Cambridge Biomedical Research Centre; European Commission; Breast Cancer Research Foundation; Cancer Australia; National Science Foundation","keywords":"PALB2; Genetics; Biology; Allele; Breast cancer; Germline mutation; Germline; Homologous recombination; Mutation; Gene; Cancer","score_opus":0.00452957797043336,"score_gpt":0.22556531874939034,"score_spread":0.221035740778957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967367406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986517,0.00029062096,0.00036762503,0.000011594368,0.0000018377034,0.0000055227533,0.0001877353,0.000014493749,0.0004689897],"genre_scores_gemma":[0.9994429,0.00006474629,0.00018771281,0.000011953546,0.0000024645362,0.000003901298,0.00015124113,0.0000038428584,0.0001311597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998528,0.00001963651,0.000015244817,0.000048570804,0.00004116635,0.000022641849],"domain_scores_gemma":[0.99978155,0.00003778362,0.00009629485,0.000021441621,0.000022819133,0.000040121842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017778718,0.00023271966,0.00014618365,0.0007868175,0.00020011704,0.00028192197,0.00014079995,0.0002128965,0.002363007],"category_scores_gemma":[0.00037488746,0.00010042333,0.00016303275,0.0005102781,0.00019350798,0.00012600186,0.00033069708,0.00014029484,0.00029354572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082712184,0.0000677516,0.5893519,0.00010689984,0.000120653895,0.0064788805,0.00020747655,0.0002760252,0.39022297,0.00016655939,0.00023501743,0.011938732],"study_design_scores_gemma":[0.00002767205,0.00017166726,0.931516,0.000014430785,0.000057007845,0.038489968,0.00021612256,0.00085435505,0.027272273,0.00021778606,0.0011543939,0.000008336427],"about_ca_topic_score_codex":0.00034923514,"about_ca_topic_score_gemma":0.0005020253,"teacher_disagreement_score":0.002363007,"about_ca_system_score_codex":0.00011370396,"about_ca_system_score_gemma":0.00007018985,"threshold_uncertainty_score":0.007905006},"labels":[],"label_agreement":null},{"id":"W2979775428","doi":"10.1038/s41523-019-0130-x","title":"Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Blockade; Breast cancer; Oncology; Cancer; Chemotherapy; PD-L1; Internal medicine; Antibody; Clinical Practice; Radiation therapy; Immunotherapy; Immunology; Receptor","score_opus":0.10722042243326235,"score_gpt":0.36058413776115533,"score_spread":0.253363715327893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979775428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013982532,0.99753284,0.00016200403,0.0006074517,0.00032185428,0.0000083139885,0.000019122348,0.000010712138,0.0011979191],"genre_scores_gemma":[0.0009569013,0.9966959,0.00026948974,0.0006839343,0.00022857144,0.000013542945,0.00003440831,0.00000268969,0.0011146101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998807,0.000025035348,0.000016223124,0.000023480794,0.000039838626,0.000014736244],"domain_scores_gemma":[0.99983406,0.000075204145,0.00002431337,0.000004455296,0.00004271828,0.000019219578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005092487,0.00068465207,0.0010987902,0.0015359882,0.00020712949,0.0009477003,0.00063254515,0.00094990735,0.0038608979],"category_scores_gemma":[0.00050910265,0.00017162194,0.00043303418,0.0013514587,0.00034982042,0.0014474714,0.0005449701,0.0020564545,0.0023763843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090047986,0.00007062113,0.0000892905,0.012002702,0.00007855826,0.00014696,0.0000373962,0.0002535309,0.0015065762,0.0042522075,0.032333624,0.94913846],"study_design_scores_gemma":[0.00003553646,0.00015846493,0.00046665582,0.0035264725,0.000096264375,0.0010772522,0.000043017906,0.00009314944,0.0004045394,0.0020759501,0.992006,0.000016788765],"about_ca_topic_score_codex":0.00045633008,"about_ca_topic_score_gemma":0.0015135241,"teacher_disagreement_score":0.0038608979,"about_ca_system_score_codex":0.00050683273,"about_ca_system_score_gemma":0.0006275588,"threshold_uncertainty_score":0.012915969},"labels":[],"label_agreement":null},{"id":"W2982449517","doi":"10.1038/s41523-019-0133-7","title":"If we build it they will come: targeting the immune response to breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Immune system; Immunotherapy; Immunology; Antigen presentation; Breast cancer; Cancer research; Medicine; Antigen; Cancer immunotherapy; Cancer; Biology; T cell; Internal medicine","score_opus":0.025922347459563594,"score_gpt":0.3392283886206269,"score_spread":0.3133060411610633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982449517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010939828,0.998154,0.00008491013,0.0004884558,0.00030473442,0.0000032554003,0.00000985757,0.0000060666184,0.0008393375],"genre_scores_gemma":[0.0005698364,0.99809664,0.00010036832,0.00037289472,0.00022437262,0.000004485751,0.000017309054,0.0000012012388,0.00061287056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999894,0.000020185922,0.00001160908,0.000015168467,0.000044335462,0.000014731256],"domain_scores_gemma":[0.99985635,0.000064067055,0.000018051238,0.0000036937022,0.00004130563,0.000016526137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035097703,0.0004795742,0.0007522187,0.0012980594,0.0001827872,0.00068458583,0.00047671737,0.0007777231,0.0023965964],"category_scores_gemma":[0.0004997749,0.00013853055,0.00030173792,0.0010099938,0.0002685668,0.0008976062,0.00044966358,0.0018190589,0.0014618983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006322679,0.00005502015,0.00015882983,0.0090863295,0.000055986347,0.00014917822,0.000045827917,0.00024732813,0.0015855221,0.0029900891,0.04542477,0.9401379],"study_design_scores_gemma":[0.000013048448,0.000084172134,0.0008363444,0.0028442703,0.000058845573,0.0010694381,0.000046074078,0.00007818041,0.00030500875,0.0016588853,0.99299616,0.000009621175],"about_ca_topic_score_codex":0.0006160065,"about_ca_topic_score_gemma":0.0014184146,"teacher_disagreement_score":0.0023965964,"about_ca_system_score_codex":0.00047026217,"about_ca_system_score_gemma":0.0005548595,"threshold_uncertainty_score":0.008017361},"labels":[],"label_agreement":null},{"id":"W2985910591","doi":"10.1038/s41523-019-0138-2","title":"Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research; Breast Cancer Research Foundation","keywords":"Menstrual cycle; Breast cancer; Endocrinology; Internal medicine; Progesterone receptor; Gene expression; Estrogen; Hormone; Cancer; Hormone receptor; Medicine; Biology; Estrogen receptor; Gene; Genetics","score_opus":0.0028448944971422234,"score_gpt":0.22628770040756366,"score_spread":0.22344280591042143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985910591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985324,0.00079146976,0.00015632986,0.000011423617,0.0000031725085,0.000005985145,0.0002922897,0.00000447093,0.00020240931],"genre_scores_gemma":[0.9988098,0.00029648215,0.00017423487,0.000014538645,0.0000042634388,0.000014451556,0.00035775756,0.0000033099584,0.0003251174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999089,0.000027304613,0.000007666211,0.000021269012,0.000014984484,0.00001990346],"domain_scores_gemma":[0.9996995,0.00009378614,0.000135424,0.000020188883,0.000028411601,0.000022854108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018731064,0.000081417624,0.00015653798,0.00049788336,0.0000974004,0.00020814985,0.000069416776,0.000114141214,0.00074224966],"category_scores_gemma":[0.00057975977,0.00008110434,0.000110636705,0.0005593526,0.000112906506,0.000073926356,0.00010623318,0.0001137659,0.00015709766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030016233,0.00006878389,0.7725835,0.000117381314,0.000089246125,0.00034075527,0.00034787777,0.00026827128,0.20121247,0.000059452894,0.00023484358,0.021675773],"study_design_scores_gemma":[0.0000065682366,0.00014574653,0.99520564,0.000003224081,0.000012758398,0.00019289083,0.000058132697,0.000089744244,0.003926926,0.00001877426,0.0003375256,0.0000020987661],"about_ca_topic_score_codex":0.00060996733,"about_ca_topic_score_gemma":0.000656093,"teacher_disagreement_score":0.00074224966,"about_ca_system_score_codex":0.00011498511,"about_ca_system_score_gemma":0.000061034283,"threshold_uncertainty_score":0.00248307},"labels":[],"label_agreement":null},{"id":"W2989510802","doi":"10.1038/s41523-019-0127-5","title":"The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of British Columbia; University of Toronto; Royal Victoria Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; McGill University; Queen's University","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH Office of the Director; Servicio Gallego de Salud; National Cancer Institute; European Regional Development Fund; Cancer Council Victoria; Medical Research Council; European Commission; Lietuvos Mokslo Taryba; Canadian Institutes of Health Research; Imperial Experimental Cancer Medicine Centre; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Federal Agency for Scientific Organizations; National Institute of General Medical Sciences; Deutschen Konsortium für Translationale Krebsforschung; KWF Kankerbestrijding; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Jewish General Hospital; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Memorial Sloan-Kettering Cancer Center; Istituto Oncologico Veneto; Institut National Du Cancer; National Health and Medical Research Council; Deutsche Krebshilfe; Fondazione Umberto Veronesi; Vetenskapsrådet; Stockholms Läns Landsting; Kuopion Yliopistollinen Sairaala; Ministero della Salute; McGill University; Generalitat de Catalunya; Cancer Center, University of Kansas; University of Southern California; Cancerfonden; Landspítali Háskólasjúkrahús; Ministerio de Economía y Competitividad; National Center for Advancing Translational Sciences; Bundesministerium für Bildung und Forschung; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Fondation ARC pour la Recherche sur le Cancer; American Cancer Society; Cancer Australia; Russian Foundation for Basic Research; Deutsche Gesetzliche Unfallversicherung; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Programme Grants for Applied Research; Robert Bosch Stiftung; Associazione Italiana per la Ricerca sul Cancro; Karolinska Institutet; Hungarian Scientific Research Fund; Harvard T.H. Chan School of Public Health; Cancer Association of South Africa; Royal Marsden NHS Foundation Trust; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya; University of Cambridge; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Government of Canada; Georgetown University; Breast Cancer Campaign; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Breast Cancer Foundation; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; McGill University Health Centre; University of California, Irvine; David F. and Margaret T. Grohne Family Foundation; Deutsches Krebsforschungszentrum; World Cancer Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Fundación Mutua Madrileña; Breast Cancer Research Foundation; University of Chicago; NRG Oncology; Fondation du cancer du sein du Québec; Universitätsklinikum Hamburg-Eppendorf; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Institut Català de la Salut; University of Pennsylvania; Liga Portuguesa Contra o Cancro; University College London; Cancer Research UK; Beckman Research Institute, City of Hope; Susan G. Komen for the Cure; Beth Israel Deaconess Medical Center; Genome Canada; Brigham and Women's Hospital; Instituto de Salud Carlos III; Ohio State University; University of California, San Francisco; U.S. Department of Health and Human Services; Rheinische Friedrich-Wilhelms-Universität Bonn; Oak Foundation; Fisher Center for Alzheimer's Research Foundation; Fanconi Anemia Research Fund; Fonds Wetenschappelijk Onderzoek","keywords":"CHEK2; Breast cancer; PALB2; Triple-negative breast cancer; Biology; Cancer; Olaparib; Cancer research; Genetics; Internal medicine; Oncology; Medicine; Germline mutation; Mutation; Gene","score_opus":0.00440340564138385,"score_gpt":0.22794918483638513,"score_spread":0.22354577919500127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989510802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922585,0.00013915103,0.00016705482,0.000032790776,0.000006761108,0.0000032643675,0.00016911591,0.000011276259,0.00024471566],"genre_scores_gemma":[0.999671,0.00003140547,0.00007747226,0.000009795517,0.0000057400816,0.0000014751915,0.00008146332,0.0000030480196,0.000118533404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997727,0.00006296028,0.00002373821,0.000070147966,0.000038887414,0.000031609125],"domain_scores_gemma":[0.99934775,0.00015034195,0.00029505926,0.000046712856,0.000046311954,0.000113761016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034781767,0.0005229406,0.00032616203,0.0006718766,0.00036609574,0.00023003118,0.00022778817,0.0004371879,0.0035205267],"category_scores_gemma":[0.00088771404,0.00013470859,0.00037906965,0.00068027485,0.00028285215,0.00008928571,0.00022135137,0.0003315709,0.00028320105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020384514,0.00007925672,0.9541625,0.000049053713,0.0003258946,0.003187504,0.00012360784,0.00021361472,0.035085924,0.00012665128,0.00039555394,0.0042119594],"study_design_scores_gemma":[0.000040371426,0.0003013749,0.98578775,0.000019077912,0.00022918149,0.009067109,0.00009548022,0.0006461387,0.002971273,0.00012659791,0.0007021412,0.000013553267],"about_ca_topic_score_codex":0.0015934667,"about_ca_topic_score_gemma":0.0010674578,"teacher_disagreement_score":0.0035205267,"about_ca_system_score_codex":0.00012358381,"about_ca_system_score_gemma":0.00011149712,"threshold_uncertainty_score":0.011777282},"labels":[],"label_agreement":null},{"id":"W2990245076","doi":"10.1038/s41523-019-0140-8","title":"Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers","year":2019,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill Genome Centre; Jewish General Hospital","funders":"Breast Cancer Research Foundation","keywords":"PALB2; Homologous recombination; Homologous chromosome; DNA repair; Genetics; Recombination; DNA; Breast cancer; Biology; Cancer; Gene; Mutation; Germline mutation","score_opus":0.0057702605526329795,"score_gpt":0.22862949549268266,"score_spread":0.2228592349400497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990245076","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021064265,0.0012294431,0.00038650283,0.024745865,0.9666421,0.000017252241,0.00057088904,0.0001852473,0.0060121506],"genre_scores_gemma":[0.020047298,0.012708599,0.005290896,0.05326652,0.31733444,0.00014732269,0.002718006,0.0010279167,0.587459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99805355,0.00020287874,0.00036333053,0.00027637143,0.0009396248,0.00016414774],"domain_scores_gemma":[0.98859495,0.0028374542,0.00054225494,0.00079112133,0.006630311,0.000603842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016549858,0.0015756254,0.0012915098,0.0035827681,0.0023217802,0.0027924865,0.0027771774,0.005277185,0.04223616],"category_scores_gemma":[0.022067616,0.00072394666,0.0011768775,0.0018961962,0.0011495075,0.0013211324,0.0010602125,0.007159385,0.023630045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003113914,0.000009480459,0.0000889843,0.00011774842,0.000009685734,0.0009348979,0.000020720025,0.000047487265,0.00009353157,0.0006809546,0.9881769,0.009788442],"study_design_scores_gemma":[0.000021864853,0.00001653584,0.0007902358,0.00023149334,0.000032293672,0.0017478202,0.000045459365,0.00013573626,0.00045906857,0.0008330927,0.9956606,0.000025729823],"about_ca_topic_score_codex":0.010247248,"about_ca_topic_score_gemma":0.017806666,"teacher_disagreement_score":0.04223616,"about_ca_system_score_codex":0.0023460423,"about_ca_system_score_gemma":0.0024045703,"threshold_uncertainty_score":0.141294},"labels":[],"label_agreement":null},{"id":"W3007147204","doi":"10.1038/s41523-020-0149-z","title":"The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Niagara Health System; Centre Hospitalier de l’Université de Montréal; McMaster University; Ontario Clinical Oncology Group; Juravinski Hospital; Juravinski Cancer Centre; Nova Scotia Health Authority; Ottawa Regional Cancer Foundation; Capital District Health Authority; Ottawa Hospital; University of Ottawa; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Dalhousie University; University of Toronto","funders":"","keywords":"Medicine; Weight loss; Randomized controlled trial; Hazard ratio; Body mass index; Breast cancer; Overweight; Obesity; Internal medicine; Confidence interval; Letrozole; Cancer; Oncology; Physical therapy; Tamoxifen","score_opus":0.012963330855708801,"score_gpt":0.3019813143102549,"score_spread":0.2890179834545461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007147204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771798,0.010276783,0.0008807979,0.0027610604,0.0012088217,0.002320443,0.0008965741,0.00017431128,0.004301381],"genre_scores_gemma":[0.98527193,0.0021732943,0.0014729218,0.0016754962,0.00066745933,0.003942416,0.00068041316,0.000014620225,0.004101368],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989918,0.00068334216,0.00006914746,0.000105718405,0.0000627905,0.00008719312],"domain_scores_gemma":[0.99917126,0.0002906682,0.00023436394,0.00006214191,0.0000388065,0.00020274037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014942987,0.0009135072,0.002217359,0.00055929174,0.00046711785,0.00075809803,0.0005955671,0.0016255395,0.00729451],"category_scores_gemma":[0.002381546,0.00040728296,0.0018070104,0.00041040152,0.00081397407,0.0006604377,0.0006221709,0.0022650019,0.0007274502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.976774,0.0028583652,0.0010127109,0.000929364,0.0012452998,0.00003500275,0.000029813107,0.00033084064,0.0010238576,0.00025735566,0.0009510449,0.014552346],"study_design_scores_gemma":[0.9517816,0.040458504,0.00382285,0.00011982462,0.0014245216,0.000029006715,0.000034334553,0.00066404796,0.00027952247,0.00032182463,0.0010504065,0.000013610106],"about_ca_topic_score_codex":0.0012081427,"about_ca_topic_score_gemma":0.0019827753,"teacher_disagreement_score":0.00729451,"about_ca_system_score_codex":0.0006841169,"about_ca_system_score_gemma":0.0009398162,"threshold_uncertainty_score":0.024402559},"labels":[],"label_agreement":null},{"id":"W3008259997","doi":"10.1038/s41523-020-0148-0","title":"The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epirubicin; Cyclophosphamide; Internal medicine; Oncology; Anthracycline; Hazard ratio; Breast cancer; Chemotherapy; Adjuvant chemotherapy; Fluorouracil; Clinical endpoint; Proportional hazards model; Adjuvant; Methotrexate; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.006323787954146343,"score_gpt":0.2503081837815237,"score_spread":0.24398439582737735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008259997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365896,0.005119822,0.000076471515,0.00013146902,0.00002281841,0.000030155254,0.00027866013,0.00000273347,0.0006788398],"genre_scores_gemma":[0.9986432,0.0005148392,0.00009162141,0.00007260933,0.000026058935,0.000028681212,0.00041853852,9.781253e-7,0.00020349598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992932,0.000498489,0.000037145855,0.00006563625,0.00005636628,0.000049139355],"domain_scores_gemma":[0.9991966,0.00030986426,0.0002544612,0.00006156387,0.000040824518,0.0001367349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015572306,0.00021625211,0.00050377165,0.0002279455,0.0001689576,0.00046923207,0.00018252892,0.0004448118,0.0009995935],"category_scores_gemma":[0.0011868728,0.00011719573,0.00063156785,0.00035781303,0.00020116579,0.00016997302,0.00016600602,0.00037568778,0.00010137566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3607308,0.0014618146,0.57022667,0.00059413613,0.0042685443,0.00016996567,0.00009639285,0.0013054428,0.011225655,0.00040480183,0.0018495041,0.047666293],"study_design_scores_gemma":[0.02416126,0.026734523,0.9343537,0.00013593935,0.004303026,0.00035308235,0.00010075743,0.0013207931,0.0030306203,0.0005757953,0.004893833,0.000036516187],"about_ca_topic_score_codex":0.00067951094,"about_ca_topic_score_gemma":0.0014752005,"teacher_disagreement_score":0.0015572306,"about_ca_system_score_codex":0.00027111068,"about_ca_system_score_gemma":0.0002613343,"threshold_uncertainty_score":0.008235514},"labels":[],"label_agreement":null},{"id":"W3016939709","doi":"10.1038/s41523-020-0156-0","title":"Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Spinal Cord Injury BC; National Circus School; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Center for Research Resources; Daiichi Sankyo Europe; National Cancer Institute; Medical Research Council; Stand Up To Cancer; National Institutes of Health; Rosetrees Trust; CRUK Lung Cancer Centre of Excellence; National Institute for Health and Care Research; University College London; Wellcome Trust; Cancer Research UK; Wallace H. Coulter Foundation; Myriad Genetics; Francis Crick Institute; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Prostate Cancer Foundation; AstraZeneca; U.S. Department of Defense; Eli Lilly and Company; Case Western Reserve University; National Breast Cancer Foundation; U.S. Department of Veterans Affairs; Breast Cancer Alliance; Pfizer; Amgen; European Commission; DOD Peer Reviewed Cancer Research Program; Breast Cancer Research Foundation","keywords":"Breast cancer; Cancer; Medicine; Stromal cell; Breast tumor; Pathology; Stromal tumor; Oncology; Internal medicine","score_opus":0.019980693724880205,"score_gpt":0.30127865816730337,"score_spread":0.28129796444242317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016939709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8105365,0.01893258,0.14701866,0.004711842,0.00083934277,0.0007173247,0.0008643511,0.0014659963,0.014913364],"genre_scores_gemma":[0.90315807,0.0019306813,0.091658436,0.00095391116,0.00020026467,0.00029382168,0.00028205724,0.0002541423,0.001268566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9714707,0.014453185,0.0045793806,0.001755871,0.007232701,0.0005081324],"domain_scores_gemma":[0.9313614,0.040153425,0.008902181,0.0085977,0.010388282,0.00059709296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04929305,0.0005504164,0.00049564155,0.0029197647,0.00071190577,0.002107648,0.0013194173,0.0009595247,0.0008577899],"category_scores_gemma":[0.07204131,0.00047441857,0.00051547866,0.0020294837,0.0014030287,0.0011598947,0.0014529756,0.0009480746,0.00064757414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013619924,0.00010439118,0.596822,0.0012353524,0.00032103178,0.0024671706,0.0051602283,0.00560876,0.024899855,0.0032338512,0.008201662,0.35058373],"study_design_scores_gemma":[0.00014390567,0.0016958051,0.71599674,0.0015734271,0.00069578545,0.022790262,0.005436667,0.046854004,0.12165063,0.01797788,0.064896196,0.00028861917],"about_ca_topic_score_codex":0.0016435134,"about_ca_topic_score_gemma":0.0038895481,"teacher_disagreement_score":0.04929305,"about_ca_system_score_codex":0.0007090911,"about_ca_system_score_gemma":0.00063492614,"threshold_uncertainty_score":0.26068974},"labels":[],"label_agreement":null},{"id":"W3025373602","doi":"10.1038/s41523-020-0155-1","title":"Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Ottawa; Ontario Institute for Cancer Research; Centre for Advancing Health Outcomes; Translational Research in Oncology; University of British Columbia","funders":"Medical Research Council; KWF Kankerbestrijding; National Institute for Health and Care Research; Francis Crick Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Clinical trial; Biomarker; Medicine; Immunotherapy; Workflow; Risk stratification; Oncology; Medical physics; Internal medicine; Computer science; Cancer; Database; Biology","score_opus":0.10303037676895636,"score_gpt":0.46580781256314774,"score_spread":0.36277743579419136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025373602","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051858807,0.33583063,0.59910864,0.023467332,0.001946159,0.0063140425,0.0023954278,0.004362955,0.021388875],"genre_scores_gemma":[0.065830894,0.14124218,0.77437305,0.005352568,0.0013241947,0.0061658574,0.002249239,0.00034365884,0.003118417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9479903,0.03408432,0.0074274032,0.0015736346,0.008245857,0.00067846815],"domain_scores_gemma":[0.9283212,0.049114868,0.008363993,0.0038280648,0.008938617,0.0014332521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0749903,0.0017163336,0.002119259,0.005137269,0.0005637479,0.0060072816,0.0026432853,0.002243486,0.0028415164],"category_scores_gemma":[0.09109348,0.0008375918,0.0037493869,0.00317165,0.0011597085,0.0030416038,0.0034471995,0.003325589,0.0013603126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003821481,0.00014674885,0.0030117314,0.027658334,0.0017098098,0.0002303612,0.00094888976,0.013102636,0.0014698548,0.071515724,0.02105865,0.8587652],"study_design_scores_gemma":[0.0006320666,0.0009390662,0.0066762976,0.055328213,0.005083401,0.0012022071,0.00051541673,0.03586212,0.0050096884,0.15939116,0.7290083,0.00035216074],"about_ca_topic_score_codex":0.0022373802,"about_ca_topic_score_gemma":0.00299089,"teacher_disagreement_score":0.0749903,"about_ca_system_score_codex":0.0029272176,"about_ca_system_score_gemma":0.0121698035,"threshold_uncertainty_score":0.39659137},"labels":[],"label_agreement":null},{"id":"W3025630280","doi":"10.1038/s41523-020-0154-2","title":"Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Université Laval; Translational Research in Oncology; University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"National Center for Research Resources; Genentech; National Institute for Health and Care Research; Cancer Research UK; Puma Biotechnology; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Daiichi Sankyo Europe; National Cancer Institute; Case Western Reserve University; G1 Therapeutics; Celgene; Eli Lilly and Company; U.S. Department of Defense; DOD Peer Reviewed Cancer Research Program; Leidos; Breast Cancer Research Foundation; Sanofi; AstraZeneca; U.S. Department of Veterans Affairs; National Institutes of Health; U.S. Department of Health and Human Services; Breast Cancer Alliance; Wallace H. Coulter Foundation; Pfizer; Amgen","keywords":"Biomarker; Oncology; Internal medicine; Medicine; Biology; Genetics","score_opus":0.03036765664404596,"score_gpt":0.34704187538045944,"score_spread":0.3166742187364135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025630280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021690219,0.95388764,0.019961078,0.00650162,0.004257615,0.00016926572,0.0006855909,0.00024692033,0.012121122],"genre_scores_gemma":[0.0150888,0.9444123,0.01877544,0.0034223804,0.0015429783,0.00032824423,0.0024220578,0.00014684955,0.013861005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996057,0.000096257725,0.00003338305,0.00006597783,0.00016209499,0.0000366874],"domain_scores_gemma":[0.99874973,0.00053706946,0.0000564308,0.000049054866,0.00052477216,0.0000829022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026684846,0.00089253264,0.00086067343,0.0013269066,0.00020472736,0.0012241098,0.0012986109,0.0011326455,0.0033067632],"category_scores_gemma":[0.003164321,0.00032201197,0.000813755,0.0010877852,0.0004259012,0.00095741614,0.00096458936,0.0017528707,0.0025955033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014215261,0.00009833429,0.0005328662,0.0035884702,0.00014492341,0.00014983068,0.00008113806,0.0043550357,0.0023259495,0.011054109,0.11224391,0.86528337],"study_design_scores_gemma":[0.000057849003,0.00020633299,0.0011616546,0.00198296,0.00017678394,0.00050461636,0.00003743978,0.0029302067,0.004217888,0.0053376495,0.98333377,0.000052876654],"about_ca_topic_score_codex":0.0034784155,"about_ca_topic_score_gemma":0.0023139447,"teacher_disagreement_score":0.0034784155,"about_ca_system_score_codex":0.0008592637,"about_ca_system_score_gemma":0.002296704,"threshold_uncertainty_score":0.0141124725},"labels":[],"label_agreement":null},{"id":"W3034928696","doi":"10.1038/s41523-020-0166-y","title":"Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Women's College Hospital; Statistics Canada; University of Toronto","funders":"Sanofi; GlaxoSmithKline; Servier; Breast Cancer Research Foundation; Pfizer; Genentech; Mersana Therapeutics; PTC Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Letrozole; Estrone; Medicine; Internal medicine; Leptin; Endocrinology; Estrogen; Body mass index; Vitamin D and neurology; Tamoxifen; Obesity; Breast cancer; Cancer","score_opus":0.029887952668226164,"score_gpt":0.31046283682795656,"score_spread":0.2805748841597304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034928696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990596,0.00047651754,0.000061548155,0.000019773444,0.0000044325825,0.000013883211,0.00016127499,0.000002390663,0.00020059211],"genre_scores_gemma":[0.99944395,0.00016449904,0.00006375325,0.000026292853,0.000008655484,0.000010372326,0.00015811001,0.0000012960519,0.00012304792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997534,0.00007005476,0.00003112381,0.000053034648,0.0000588015,0.00003359966],"domain_scores_gemma":[0.9992059,0.00016652531,0.00026497344,0.00010237833,0.00007383887,0.00018637735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055787293,0.00030851684,0.0004209685,0.0004508256,0.00048547596,0.0006364626,0.00021817196,0.0005332863,0.0011562367],"category_scores_gemma":[0.0014109282,0.0005105338,0.00045199605,0.0007519764,0.00027735505,0.00031541166,0.00029751225,0.0007711282,0.00028652174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009453009,0.00011580175,0.99732685,0.0000098178725,0.000109248955,0.00007406542,0.00004572805,0.000017792407,0.00048810575,0.000008203625,0.000035354708,0.00082379015],"study_design_scores_gemma":[0.000072024624,0.0008218575,0.99798346,0.000007652485,0.00013001652,0.0003641771,0.0000874436,0.000120377576,0.000120866585,0.000016287777,0.00026991585,0.000005917162],"about_ca_topic_score_codex":0.0016113435,"about_ca_topic_score_gemma":0.0019636098,"teacher_disagreement_score":0.0016113435,"about_ca_system_score_codex":0.00014881464,"about_ca_system_score_gemma":0.0002310524,"threshold_uncertainty_score":0.0038679838},"labels":[],"label_agreement":null},{"id":"W3043321283","doi":"10.1038/s41523-020-0171-1","title":"Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cure Brain Cancer Foundation","keywords":"Cyclophosphamide; Medicine; Metastatic breast cancer; Regimen; Breast cancer; Cancer; CD8; Immune system; Primary tumor; Oncology; Combination therapy; Cancer research; Concomitant; Blockade; Immunotherapy; Mammary tumor; Chemotherapy; Internal medicine; Immunology; Metastasis; Receptor","score_opus":0.01242845385308866,"score_gpt":0.26374376268641,"score_spread":0.2513153088333213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043321283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722004,0.0007694172,0.00040499453,0.000060758997,0.000054164466,0.00007764148,0.00036756427,0.00006279432,0.0009825715],"genre_scores_gemma":[0.99581355,0.0007097823,0.0008982382,0.000053937143,0.000021987475,0.000104144696,0.00051794446,0.000020789406,0.0018596527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998115,0.00004014861,0.0000127547555,0.00002371666,0.000045373792,0.000066542234],"domain_scores_gemma":[0.9998517,0.000026610845,0.000030219417,0.000016170505,0.000014904472,0.000060287344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000204335,0.0005009565,0.0005190181,0.00036977677,0.00014093267,0.00025957543,0.00024925225,0.00029731035,0.0013629788],"category_scores_gemma":[0.00011631407,0.00015998314,0.0002690571,0.00019508823,0.00027314006,0.00018836967,0.00013472041,0.0008873398,0.00022789983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013804903,0.0011165086,0.00025942127,0.00009732196,0.000013711835,0.000048641472,0.000035695186,0.00048280138,0.99370193,0.00008985947,0.00018732717,0.0025862518],"study_design_scores_gemma":[0.00014935761,0.017910343,0.0033250412,0.000009485091,0.00003795433,0.00015161016,0.000031021147,0.00085333554,0.9763274,0.000026812075,0.0011713866,0.0000062923473],"about_ca_topic_score_codex":0.0010259085,"about_ca_topic_score_gemma":0.0019479629,"teacher_disagreement_score":0.0013629788,"about_ca_system_score_codex":0.00036841855,"about_ca_system_score_gemma":0.00027195748,"threshold_uncertainty_score":0.004559636},"labels":[],"label_agreement":null},{"id":"W3048442532","doi":"10.1038/s41523-020-00177-6","title":"Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; NODAL; Disease; Cancer","score_opus":0.010404536266655875,"score_gpt":0.2591173577331325,"score_spread":0.2487128214664766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048442532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788576,0.0013401766,0.00003853474,0.000037580285,0.000004815003,0.000003038169,0.00016526213,0.0000015041234,0.00052338495],"genre_scores_gemma":[0.9993086,0.00022048352,0.00003791652,0.000017169988,0.0000071457916,0.0000019276818,0.00030167983,6.565316e-7,0.00010430669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974376,0.000084753476,0.000032764656,0.000036627716,0.00006479246,0.000037231992],"domain_scores_gemma":[0.99865025,0.0004997236,0.00047771915,0.00009177859,0.0000997077,0.00018082284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008320458,0.00008284158,0.00016701978,0.00034173668,0.00010734332,0.00029328724,0.00022369689,0.00014410313,0.00045429732],"category_scores_gemma":[0.002265559,0.00004447036,0.00016640745,0.0004209053,0.00023768241,0.00020875088,0.00016940074,0.00022795983,0.00008036174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007074488,0.000027198748,0.9912429,0.000017121656,0.000029853583,0.00010775754,0.000035034867,0.00017281053,0.00049635733,0.00001730989,0.00007307035,0.007073291],"study_design_scores_gemma":[0.0000069621606,0.00030454554,0.99846905,0.000008945493,0.000037406746,0.00024847445,0.00007944462,0.00020622331,0.00024480495,0.000021011718,0.00037025867,0.000002893254],"about_ca_topic_score_codex":0.0035640632,"about_ca_topic_score_gemma":0.00883644,"teacher_disagreement_score":0.0035640632,"about_ca_system_score_codex":0.00043369143,"about_ca_system_score_gemma":0.00029970176,"threshold_uncertainty_score":0.0070866346},"labels":[],"label_agreement":null},{"id":"W3083798800","doi":"10.1038/s41523-020-00185-6","title":"Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Medical Research Council; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; Odense Universitetshospital; Fondation du cancer du sein du Québec; Génome Québec; Genome Canada; National Institutes of Health; National Health and Medical Research Council; Cancer Research UK; Government of Canada; Deutsche Krebshilfe; Breast Cancer Research Foundation","keywords":"Germline; Breast cancer; Germline mutation; Oncology; Genetics; Variation (astronomy); Biology; Medicine; Internal medicine; Cancer; Mutation; Gene","score_opus":0.005966913367636,"score_gpt":0.2273153082776421,"score_spread":0.2213483949100061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083798800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933076,0.00016703461,0.0001352734,0.000027574448,0.000004766543,9.835596e-7,0.00012857946,0.0000034887944,0.0002016056],"genre_scores_gemma":[0.99977225,0.00002580756,0.0000424592,0.0000063105454,0.000003929586,7.295281e-7,0.00007442036,8.972031e-7,0.00007316442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998049,0.00006137336,0.000016470565,0.000054462114,0.000028778122,0.000034049877],"domain_scores_gemma":[0.99923384,0.0003036908,0.00025626016,0.00006448166,0.00005339125,0.0000884439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042146965,0.00014120452,0.00014506724,0.00035301247,0.00018440578,0.00024819578,0.00015647306,0.00021764048,0.001996116],"category_scores_gemma":[0.0015528441,0.00006905727,0.00022777668,0.00035862208,0.00018151967,0.00009603188,0.0001925667,0.0002816654,0.000115372495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003646973,0.000024106252,0.994689,0.000006353207,0.0001151275,0.00014732772,0.00002486077,0.0001336221,0.0023377854,0.00005003432,0.000081751605,0.0020253728],"study_design_scores_gemma":[0.000007912431,0.00011183763,0.99808276,0.0000025102106,0.000058742833,0.0005026602,0.000036562153,0.00045889165,0.0005076218,0.000086796,0.00014095908,0.000002671876],"about_ca_topic_score_codex":0.0011549047,"about_ca_topic_score_gemma":0.0010596481,"teacher_disagreement_score":0.001996116,"about_ca_system_score_codex":0.000089396126,"about_ca_system_score_gemma":0.00010987573,"threshold_uncertainty_score":0.006677747},"labels":[],"label_agreement":null},{"id":"W3128758614","doi":"10.1038/s41523-021-00222-y","title":"Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Organisation for Research and Treatment of Cancer; University of Nottingham; National Institute for Health and Care Research; Cancer Research UK; AstraZeneca","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Endocrine system; Internal medicine; Hormone; Hormone receptor; Cancer; Endocrinology","score_opus":0.06251399066135013,"score_gpt":0.36516630094651714,"score_spread":0.30265231028516704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128758614","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03127953,0.9607826,0.0028190007,0.00055684923,0.00065969245,0.00043317853,0.0023353493,0.00015440524,0.0009794729],"genre_scores_gemma":[0.74961764,0.23640686,0.0049465722,0.0020211965,0.00061250007,0.0014518257,0.0033766457,0.00019038179,0.0013764447],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9823455,0.012393832,0.0023194265,0.0016807358,0.00089742395,0.00036311717],"domain_scores_gemma":[0.972099,0.022393309,0.0027566447,0.0014431084,0.0009072315,0.00040064123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024996962,0.004426728,0.019281147,0.0042642257,0.00057433,0.0036040994,0.0024522569,0.0026423302,0.0044311057],"category_scores_gemma":[0.035997104,0.0017061578,0.07167463,0.004659805,0.0007766396,0.0016306932,0.0017466797,0.0032954642,0.0005112372],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005173763,0.00001443265,0.002119543,0.02697627,0.9623663,0.00006011213,0.000017923614,0.00090477907,0.00019725993,0.000068041554,0.00027758398,0.001824123],"study_design_scores_gemma":[0.0007867136,0.0001589446,0.0020777462,0.0009507509,0.9949215,0.000037740774,0.0000108519835,0.00027007132,0.00009393333,0.0001588096,0.0005226933,0.000010237421],"about_ca_topic_score_codex":0.005330271,"about_ca_topic_score_gemma":0.007201209,"teacher_disagreement_score":0.024996962,"about_ca_system_score_codex":0.0019971004,"about_ca_system_score_gemma":0.0013356229,"threshold_uncertainty_score":0.13219815},"labels":[],"label_agreement":null},{"id":"W3132376902","doi":"10.1038/s41523-021-00220-0","title":"Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"University of Toronto","keywords":"Trastuzumab; Medicine; Internal medicine; Oncology; Incidence (geometry); Breast cancer; Meta-analysis; Randomized controlled trial; Targeted therapy; Observational study; Metastatic breast cancer; Surgery; Cancer","score_opus":0.16813124575614494,"score_gpt":0.43838207818789926,"score_spread":0.2702508324317543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132376902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006757427,0.9912185,0.0005157977,0.00016215837,0.00011259344,0.00021530631,0.0007377808,0.000021576356,0.00025889516],"genre_scores_gemma":[0.21458127,0.7796007,0.0020960823,0.0009639961,0.00024952425,0.00094161666,0.0011865703,0.000037634643,0.00034258634],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9912156,0.0038192736,0.0029206702,0.0009901642,0.00080581167,0.00024845495],"domain_scores_gemma":[0.9762966,0.017791316,0.0037123451,0.00064090954,0.0013256103,0.0002332113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012737372,0.0021496376,0.016801165,0.005001606,0.00046321805,0.0029849738,0.00180335,0.0016998452,0.0027306862],"category_scores_gemma":[0.028412197,0.0012356355,0.03240258,0.00674314,0.00065745565,0.0013910912,0.0012343158,0.0015469467,0.0002567079],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018870601,0.000020240856,0.0050938968,0.34794468,0.6350767,0.00009996112,0.00005651505,0.00048315804,0.00017378801,0.00011476765,0.0005232217,0.008526055],"study_design_scores_gemma":[0.0004329757,0.00012358437,0.0034733454,0.017999351,0.9764534,0.00007909331,0.000025495392,0.00014692644,0.00009472904,0.00014210942,0.0010114091,0.000017589598],"about_ca_topic_score_codex":0.005292463,"about_ca_topic_score_gemma":0.010850828,"teacher_disagreement_score":0.016801165,"about_ca_system_score_codex":0.0020832582,"about_ca_system_score_gemma":0.0026771151,"threshold_uncertainty_score":0.06736249},"labels":[],"label_agreement":null},{"id":"W3135423629","doi":"10.1038/s41523-021-00226-8","title":"Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Botwinick-Wolfensohn Foundation; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; U.S. Department of Health and Human Services","keywords":"Breast cancer; Aromatase; Medicine; Internal medicine; Endocrinology; Leptin; Body mass index; Adiponectin; Adipose tissue; Obesity; Cancer; Oncology; Insulin resistance","score_opus":0.006200436157666598,"score_gpt":0.25066690108648804,"score_spread":0.24446646492882143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135423629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988262,0.00073782704,0.000034470802,0.000043564665,0.0000045611355,0.000002814258,0.000046518522,0.0000010826985,0.0003030769],"genre_scores_gemma":[0.99936086,0.00027795197,0.000056384724,0.000023309527,0.000006117641,0.000003695648,0.000041145548,7.062017e-7,0.0002297494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992955,0.000027809649,0.000003226294,0.0000144987935,0.000011065554,0.000013794873],"domain_scores_gemma":[0.9998363,0.000041672854,0.000059229857,0.000011558456,0.000009443477,0.00004173577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017102405,0.00013758849,0.00012528445,0.00024771705,0.00011972969,0.00019912103,0.000047435064,0.00014470748,0.0007461626],"category_scores_gemma":[0.00048621994,0.00013085124,0.00015292516,0.0001753706,0.00015885389,0.00009039083,0.00012839204,0.00025024448,0.00007244477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021982554,0.00015831264,0.9813756,0.00003112082,0.00012699359,0.00034073487,0.00011064025,0.00004538671,0.0077680955,0.000044988305,0.00010467589,0.0076952092],"study_design_scores_gemma":[0.000007227263,0.00021020704,0.99917465,0.0000034008638,0.00002440174,0.00018194175,0.000038769456,0.00003662625,0.00021910292,0.000017527873,0.000084886866,0.0000012054792],"about_ca_topic_score_codex":0.0008991204,"about_ca_topic_score_gemma":0.0015795112,"teacher_disagreement_score":0.0008991204,"about_ca_system_score_codex":0.00009317801,"about_ca_system_score_gemma":0.00009165529,"threshold_uncertainty_score":0.002496183},"labels":[],"label_agreement":null},{"id":"W3136326764","doi":"10.1038/s41523-021-00238-4","title":"Co-dependency for MET and FGFR1 in basal triple-negative breast cancers","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Genome Canada; Canadian Institutes of Health Research; Deutsches Krebsforschungszentrum; Genentech; McGill University","keywords":"Triple-negative breast cancer; Cancer research; Fibroblast growth factor receptor 1; Breast cancer; Basal (medicine); Carcinogenesis; Medicine; Biology; Cancer; Oncology; Internal medicine; Receptor; Fibroblast growth factor","score_opus":0.01924902441114627,"score_gpt":0.32035437160245767,"score_spread":0.3011053471913114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136326764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357224,0.002628562,0.001033625,0.000100724064,0.000011281555,0.000014129244,0.00030697358,0.000062698586,0.0022697048],"genre_scores_gemma":[0.99747986,0.00047550254,0.0006598404,0.00002213287,0.0000025860243,0.000010834806,0.00022125959,0.000007423091,0.0011204643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998061,0.000029099561,0.000013477533,0.000029958584,0.00007983289,0.00004152782],"domain_scores_gemma":[0.9998839,0.000021478896,0.00003083122,0.0000138362975,0.000013911265,0.00003593719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583681,0.00017966119,0.00025953213,0.00029442497,0.00015478375,0.0004414187,0.00016389172,0.00023061752,0.0013708078],"category_scores_gemma":[0.00016603293,0.00011285698,0.00015633258,0.00016474939,0.00019909749,0.00017963893,0.00023137935,0.00034283573,0.00038403645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001513865,0.000018162787,0.0019233241,0.000040028324,0.0000060151015,0.00020862687,0.000016544802,0.000059955346,0.9954946,0.000118002405,0.000047519225,0.0019156925],"study_design_scores_gemma":[0.000016762904,0.00059798575,0.06160121,0.00001455874,0.000040830142,0.007310388,0.00010082213,0.0015191325,0.9236436,0.00012327437,0.005019957,0.000011464639],"about_ca_topic_score_codex":0.001047022,"about_ca_topic_score_gemma":0.0019810551,"teacher_disagreement_score":0.0013708078,"about_ca_system_score_codex":0.0002930673,"about_ca_system_score_gemma":0.000212274,"threshold_uncertainty_score":0.004585862},"labels":[],"label_agreement":null},{"id":"W3153071119","doi":"10.1038/s41523-021-00251-7","title":"Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; Astex Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; AstraZeneca; National Cancer Institute; National Institutes of Health; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Fulvestrant; PTEN; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Anastrozole; Cancer; Aromatase inhibitor; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Biology; Aromatase; Signal transduction","score_opus":0.007119816247072573,"score_gpt":0.25377119702037226,"score_spread":0.24665138077329968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153071119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707305,0.0018099749,0.00017442707,0.00007984627,0.000022661243,0.00009701674,0.0000957914,0.00003060629,0.0006166486],"genre_scores_gemma":[0.99742943,0.0014168306,0.00030292507,0.00006779048,0.000026420272,0.00007741495,0.00020299817,0.000004710612,0.00047142885],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999156,0.000028587792,0.0000060883763,0.000012418096,0.000016373122,0.000021015527],"domain_scores_gemma":[0.99992347,0.00001532967,0.000016405795,0.000009257391,0.0000057567077,0.0000297411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032546904,0.0003829784,0.0006034681,0.00021273173,0.00012101916,0.00027761565,0.00026252074,0.00018063634,0.0007010548],"category_scores_gemma":[0.00022485972,0.00014663277,0.00030355802,0.00023934248,0.00016384826,0.00021744696,0.00014950302,0.0006753085,0.000118533826],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09687041,0.018349359,0.012231926,0.0008346323,0.0010125813,0.0009033727,0.0002645549,0.009823129,0.42199725,0.00044119215,0.003723692,0.43354785],"study_design_scores_gemma":[0.071691416,0.5608852,0.11236233,0.0001421543,0.0016274627,0.0042020995,0.00024500885,0.01817442,0.21282044,0.0005263651,0.01723198,0.000091053655],"about_ca_topic_score_codex":0.0004696677,"about_ca_topic_score_gemma":0.0016076879,"teacher_disagreement_score":0.0007010548,"about_ca_system_score_codex":0.00029400032,"about_ca_system_score_gemma":0.0003342359,"threshold_uncertainty_score":0.0023452044},"labels":[],"label_agreement":null},{"id":"W3160306401","doi":"10.1038/s41523-021-00255-3","title":"Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Université Laval; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Instituto de Salud Carlos III; Medical Research Council; Freistaat Sachsen; Unicancer; Canadian Institutes of Health Research; Direction Générale de l’offre de Soins; Universität Leipzig; National Health and Medical Research Council; Institut National Du Cancer; Agence Nationale de la Recherche; Cancer Australia; European Regional Development Fund; National Breast Cancer Foundation; Fundación Cellex; European Commission; University of Cambridge; Cancer Research UK; Centres de Recerca de Catalunya; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Canada; Fondation du cancer du sein du Québec; Generalitat de Catalunya; National Institute for Health and Care Research; Genome Canada; Cancer Council Victoria; Deutsche Krebshilfe; Victorian Cancer Agency","keywords":"Breast cancer; Missense mutation; Germline mutation; Germline; Allele; Male breast cancer; Haploinsufficiency; Penetrance; Genetics; Biology; PALB2; Cancer; Oncology; Cancer research; Medicine; Mutation; Gene; Phenotype","score_opus":0.025901240004550078,"score_gpt":0.3266547738514796,"score_spread":0.30075353384692954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160306401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995196,0.00006023991,0.000097275944,0.0000089284285,0.0000013863499,0.0000084863905,0.00012960893,0.0000023646878,0.00017201371],"genre_scores_gemma":[0.9993687,0.000050671908,0.00010209412,0.000013452007,0.000005267635,0.000011277936,0.00034292444,0.0000030367357,0.00010273737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993832,0.00017035994,0.000042158073,0.00023732957,0.00007848617,0.000088401466],"domain_scores_gemma":[0.9991591,0.00018612067,0.0002293904,0.00014936189,0.0000829478,0.00019314804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081677426,0.00048978964,0.0005132021,0.0009725055,0.0007494693,0.0005267275,0.0003859512,0.0004788748,0.0012654985],"category_scores_gemma":[0.0014639881,0.00048818838,0.00039936422,0.0011071238,0.00044542772,0.00025377696,0.00056910014,0.0004778493,0.00025099193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017891967,0.000048156402,0.99708873,0.000009137708,0.00011106282,0.00016655897,0.00021999626,0.000031233216,0.0011737269,0.000017082137,0.00004679057,0.0009085961],"study_design_scores_gemma":[0.000014309337,0.00016858759,0.9986915,0.000002830201,0.00007432785,0.000447276,0.00018752,0.000115114206,0.00015482452,0.000012022386,0.00012846291,0.000003291568],"about_ca_topic_score_codex":0.005313591,"about_ca_topic_score_gemma":0.0037831583,"teacher_disagreement_score":0.005313591,"about_ca_system_score_codex":0.00024209477,"about_ca_system_score_gemma":0.00021036413,"threshold_uncertainty_score":0.0105653405},"labels":[],"label_agreement":null},{"id":"W3161898366","doi":"10.1038/s41523-021-00264-2","title":"NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Montreal General Hospital","funders":"National Cancer Institute; American College of Radiology Imaging Network; Genentech; F. Hoffmann-La Roche; Breast Cancer Research Foundation","keywords":"Medicine; Trastuzumab; Amenorrhea; Gynecology; Breast cancer; Oophorectomy; Internal medicine; Oncology; Triptorelin; Obstetrics; Hysterectomy; Cancer; Hormone; Luteinizing hormone; Pregnancy; Surgery; Gonadotropin-releasing hormone","score_opus":0.006946025991060778,"score_gpt":0.28215748754823666,"score_spread":0.2752114615571759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161898366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964809,0.0017993697,0.000034832854,0.00030283188,0.000028492204,0.00007048123,0.00045222236,0.000003119422,0.00082782016],"genre_scores_gemma":[0.99719584,0.0008817244,0.00011688913,0.00032677955,0.00009907913,0.00005504743,0.0006387103,0.0000056183776,0.00068033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940467,0.0003671805,0.000024535362,0.000045321,0.0000859102,0.000072398514],"domain_scores_gemma":[0.999111,0.00024005715,0.00022582144,0.00007890407,0.00002936974,0.00031481546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013517728,0.00018736745,0.0005952632,0.00019301633,0.00016694287,0.00033883742,0.00022083531,0.00029001012,0.0011942185],"category_scores_gemma":[0.0018583551,0.00013922433,0.0005092849,0.0002995766,0.00021116735,0.00020463564,0.00027174054,0.0005385982,0.00015370185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4123539,0.0074486476,0.44741893,0.00027509814,0.0029015257,0.00043839504,0.0001905472,0.00073585374,0.0071078986,0.00023490639,0.004063086,0.116831295],"study_design_scores_gemma":[0.019580945,0.046160664,0.9255815,0.00005092642,0.0013107506,0.0003390049,0.00010024847,0.0006113785,0.0009286321,0.00010622119,0.005212772,0.000016912445],"about_ca_topic_score_codex":0.0035341543,"about_ca_topic_score_gemma":0.0046659443,"teacher_disagreement_score":0.0035341543,"about_ca_system_score_codex":0.0005879528,"about_ca_system_score_gemma":0.0008499066,"threshold_uncertainty_score":0.0071489215},"labels":[],"label_agreement":null},{"id":"W3164338067","doi":"10.1038/s41523-021-00266-0","title":"Anti-tumor effects of an ID antagonist with no observed acquired resistance","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Social Fund; Fonds de Recherche du Québec - Santé; National Cancer Institute; National Institutes of Health; Botwinick-Wolfensohn Foundation; Fonds de recherche du Québec – Nature et technologies; American Concrete Institute Foundation; Generalitat Valenciana; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Paclitaxel; Cancer research; Biology; Reactive oxygen species; Transcription factor; Cell growth; Cancer; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.006295913903447121,"score_gpt":0.23358899867716773,"score_spread":0.22729308477372062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164338067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924375,0.003099293,0.00070475903,0.00026530397,0.00011166044,0.000071997354,0.00057669356,0.00012942319,0.005797212],"genre_scores_gemma":[0.99203604,0.0013170193,0.0007974764,0.0001543162,0.000023816649,0.000042848224,0.0010014111,0.000012066225,0.0046150875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999342,0.000012545755,0.0000051915854,0.000009868476,0.0000123226855,0.000025817057],"domain_scores_gemma":[0.9999473,0.0000123622085,0.000007364065,0.00000862169,0.0000067349088,0.000017591901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009661725,0.0002042074,0.00036891375,0.00017643532,0.00012538426,0.00023952856,0.00023662533,0.0002976257,0.0027795343],"category_scores_gemma":[0.00010386134,0.000083779254,0.00016757587,0.00011389105,0.0001392955,0.0001365049,0.00007606112,0.00070371217,0.00043514723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016273546,0.0010554,0.0005134973,0.00017428098,0.00004520662,0.0003364184,0.00003427119,0.0003798009,0.9688292,0.0006555394,0.0011723922,0.025176644],"study_design_scores_gemma":[0.0011584437,0.020058358,0.014279566,0.000031932104,0.00012259379,0.00294724,0.000078902056,0.0024377815,0.9285656,0.00020860888,0.030082466,0.000028395123],"about_ca_topic_score_codex":0.00038073582,"about_ca_topic_score_gemma":0.0008648056,"teacher_disagreement_score":0.0027795343,"about_ca_system_score_codex":0.0001607894,"about_ca_system_score_gemma":0.0002634746,"threshold_uncertainty_score":0.009298503},"labels":[],"label_agreement":null},{"id":"W3167217140","doi":"10.1038/s41523-021-00275-z","title":"Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Université Laval; McMaster University; Juravinski Cancer Centre; University of British Columbia; Saint John Regional Hospital; Roche (Canada); BC Cancer Agency; Niagara Health System; Grand River Hospital; Queen's University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Metformin; Placebo; Medicine; Breast cancer; Oncology; Internal medicine; Randomized controlled trial; Cancer; Insulin; Pathology; Alternative medicine","score_opus":0.010174329374079399,"score_gpt":0.2891731375598405,"score_spread":0.27899880818576106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167217140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822573,0.011787789,0.0002916358,0.0013854299,0.000731629,0.00091066555,0.00060159044,0.00009480551,0.001939248],"genre_scores_gemma":[0.9935183,0.0015407138,0.00048372598,0.00067218486,0.00037939457,0.0012021703,0.00033092205,0.000009368718,0.0018632828],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990582,0.00065176026,0.000055774737,0.000105131825,0.000051650048,0.00007755247],"domain_scores_gemma":[0.9994018,0.00018390313,0.00020075995,0.000037985097,0.00003071935,0.00014480401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013222886,0.0013177226,0.00310589,0.00040457558,0.0003355596,0.000918846,0.00052843074,0.0016503234,0.004400579],"category_scores_gemma":[0.0023649738,0.00040943237,0.0013149657,0.00032944372,0.0005321423,0.00064198027,0.00033943882,0.001768972,0.00053067645],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.987632,0.0009146261,0.0007328734,0.0004079889,0.0006474895,0.000025791767,0.000012251095,0.0001821324,0.0018462973,0.000090014386,0.0005730127,0.006935511],"study_design_scores_gemma":[0.9222959,0.06736375,0.005786195,0.00013431371,0.0016481034,0.00005015812,0.000023991563,0.0008362347,0.00063152716,0.00039669982,0.00081063283,0.000022488948],"about_ca_topic_score_codex":0.0005506956,"about_ca_topic_score_gemma":0.0011552409,"teacher_disagreement_score":0.004400579,"about_ca_system_score_codex":0.000569027,"about_ca_system_score_gemma":0.0006159607,"threshold_uncertainty_score":0.014721394},"labels":[],"label_agreement":null},{"id":"W3169325545","doi":"10.1038/s41523-021-00281-1","title":"Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Menarini Silicon Biosystems; Fashion Footwear Association of New York","keywords":"Medicine; Metastatic breast cancer; Circulating tumor cell; Internal medicine; Oncology; Progression-free survival; Clinical endpoint; Estrogen receptor; Cancer; Breast cancer; Metastasis; Chemotherapy; Clinical trial","score_opus":0.011549705273601092,"score_gpt":0.28419366661870843,"score_spread":0.2726439613451073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169325545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989785,0.0004620914,0.00007884314,0.000024950483,0.0000053454805,0.000005866966,0.00015497554,0.0000044873814,0.0002850091],"genre_scores_gemma":[0.9994923,0.00006758994,0.00006599339,0.000018545643,0.000012350503,0.00000633805,0.00024037813,0.0000011432588,0.00009531183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997614,0.00005631573,0.00003432277,0.000055912715,0.000055240074,0.00003688165],"domain_scores_gemma":[0.9987457,0.00037033387,0.00046832362,0.00006237379,0.00009854242,0.0002546337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004379838,0.00015224017,0.00039018478,0.00042797485,0.00017873186,0.0004321824,0.00018767874,0.00035077668,0.0010257164],"category_scores_gemma":[0.002638376,0.00015586922,0.00016112337,0.0006503252,0.0001471802,0.00032633558,0.00022681769,0.00038881093,0.00019807067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010758818,0.00003964183,0.99481237,0.000009092613,0.00002682656,0.00010241528,0.000022238068,0.00012448538,0.00069737254,0.000017218532,0.00012323586,0.0029491393],"study_design_scores_gemma":[0.00006805015,0.0004881254,0.9973788,0.000005417947,0.00003998555,0.0005861344,0.000037532332,0.00077455264,0.0002795343,0.000044927772,0.00029124762,0.0000055818123],"about_ca_topic_score_codex":0.00091395114,"about_ca_topic_score_gemma":0.0011632235,"teacher_disagreement_score":0.0010257164,"about_ca_system_score_codex":0.0002628085,"about_ca_system_score_gemma":0.00014531547,"threshold_uncertainty_score":0.0034313202},"labels":[],"label_agreement":null},{"id":"W3180645260","doi":"10.1038/s41523-021-00297-7","title":"Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"University College London; Government of Ontario; National Cancer Institute; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; National Institute for Health and Care Research; Genome Canada","keywords":"Medicine; Risk stratification; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.021370798486590563,"score_gpt":0.3242992406460176,"score_spread":0.30292844215942705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180645260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875494,0.0020781334,0.006590814,0.00028630183,0.00019944648,0.00007658383,0.0010346235,0.00002366265,0.0021610342],"genre_scores_gemma":[0.9979857,0.00007168709,0.00087420875,0.00008829755,0.00008188796,0.00003849808,0.00071730214,0.000015952226,0.0001264371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9676021,0.023715403,0.0013364276,0.0028672856,0.003324654,0.0011542033],"domain_scores_gemma":[0.84751797,0.10631242,0.012701049,0.023378452,0.0069003776,0.003189802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037954606,0.00039286094,0.0008883097,0.0019144864,0.00046403785,0.0019271079,0.001573894,0.0011277281,0.002632525],"category_scores_gemma":[0.08147946,0.00025565812,0.001997612,0.0017426643,0.0009115579,0.0016026556,0.001647565,0.0013079129,0.00058660994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010474281,0.00014134942,0.95687157,0.00018987512,0.005385069,0.00044652945,0.0006094179,0.00087542523,0.0015495833,0.0010809539,0.0016459761,0.020729885],"study_design_scores_gemma":[0.00020077877,0.0052288333,0.97314894,0.00011848297,0.0028601247,0.0016887325,0.0016211553,0.0065455325,0.0011458935,0.0030658478,0.0042850636,0.00009065088],"about_ca_topic_score_codex":0.00069236313,"about_ca_topic_score_gemma":0.0009115761,"teacher_disagreement_score":0.037954606,"about_ca_system_score_codex":0.00048196473,"about_ca_system_score_gemma":0.0005138274,"threshold_uncertainty_score":0.20072556},"labels":[],"label_agreement":null},{"id":"W3181590127","doi":"10.1038/s41523-021-00299-5","title":"High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology, Taiwan; National Taiwan University Hospital; National Research Foundation Singapore; Cancer Research UK; BC Cancer Agency; Ministry of Education; National Taiwan University; Ministry of Education - Singapore; National Research Foundation; Ministry of Health and Welfare","keywords":"Breast cancer; Copy-number variation; Medicine; Oncology; Estrogen receptor; Cancer; Incidence (geometry); Immune system; Gene; East Asia; Internal medicine; Cancer research; Biology; Immunology; Genetics; China","score_opus":0.010257244113006107,"score_gpt":0.2576346292176395,"score_spread":0.24737738510463342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181590127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999708,0.000094956384,0.00003647808,0.000006492074,6.712815e-7,0.0000015336769,0.000062280684,0.0000018120694,0.00008776177],"genre_scores_gemma":[0.9996462,0.00007760952,0.000059482463,0.000009427599,0.0000020075065,0.0000020408788,0.00013263975,0.0000013271185,0.00006925805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998435,0.00002167722,0.00002367595,0.000052276122,0.000035674828,0.000023210001],"domain_scores_gemma":[0.9997098,0.000052566065,0.00012859327,0.000030675026,0.00003646128,0.000041899773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024610682,0.00013231536,0.00018624247,0.00079680886,0.00026632473,0.0003991098,0.00015551604,0.00017699694,0.00065704406],"category_scores_gemma":[0.0005506171,0.00010818782,0.00019187336,0.000657742,0.00023499395,0.00013841527,0.0002164266,0.00013804687,0.00009132202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011909107,0.000010042154,0.98966414,0.000014139347,0.000049239563,0.00029257467,0.00017822634,0.000041101823,0.0067401095,0.000027665681,0.000041316358,0.0028224364],"study_design_scores_gemma":[0.0000022581805,0.000023322806,0.99835604,0.0000033137408,0.000028511322,0.0005690452,0.0001828197,0.00013090442,0.00055855664,0.000022210315,0.000120966724,0.0000021045987],"about_ca_topic_score_codex":0.0034183818,"about_ca_topic_score_gemma":0.0037075523,"teacher_disagreement_score":0.0034183818,"about_ca_system_score_codex":0.00017198364,"about_ca_system_score_gemma":0.00016193568,"threshold_uncertainty_score":0.006796956},"labels":[],"label_agreement":null},{"id":"W3184508197","doi":"10.1038/s41523-021-00307-8","title":"Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Trastuzumab; Pertuzumab; Docetaxel; Internal medicine; Oncology; Tamoxifen; Population; Prospective cohort study; Gynecology; Cohort; Amenorrhea; Cancer; Pregnancy","score_opus":0.009360194591843056,"score_gpt":0.27401105206301024,"score_spread":0.2646508574711672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184508197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985331,0.00025725513,0.00007209922,0.000049647104,0.000013018984,0.000017349103,0.0007274399,0.0000018306952,0.00032835535],"genre_scores_gemma":[0.99924314,0.000119641285,0.000054077398,0.000064273765,0.000011369331,0.0000145541235,0.00034099992,0.0000014369801,0.0001505944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959105,0.00011493902,0.00004919673,0.0000972356,0.0000817233,0.000065795524],"domain_scores_gemma":[0.9992078,0.000102839826,0.0003787672,0.000075977296,0.00007720608,0.00015745818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062168844,0.00014326669,0.00022870328,0.00059228163,0.0004978658,0.00055366557,0.00023272188,0.00030751928,0.0016605154],"category_scores_gemma":[0.0016973112,0.0002777742,0.00038224488,0.00092097814,0.00018874364,0.00047349854,0.00033585101,0.00046107086,0.00021581007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031826257,0.000020601594,0.9992736,0.0000041912435,0.00002483766,0.000030670417,0.000055827262,0.00000493538,0.00008221821,0.0000075762723,0.00006999964,0.00039358562],"study_design_scores_gemma":[0.0000054291545,0.000048249996,0.99942684,0.000004452726,0.000014315749,0.000114397575,0.00018391879,0.00003528207,0.000013446363,0.000008629784,0.00014324675,0.0000017662196],"about_ca_topic_score_codex":0.012867709,"about_ca_topic_score_gemma":0.015885811,"teacher_disagreement_score":0.012867709,"about_ca_system_score_codex":0.00024036219,"about_ca_system_score_gemma":0.00031588954,"threshold_uncertainty_score":0.025585651},"labels":[],"label_agreement":null},{"id":"W3186156042","doi":"10.1038/s41523-021-00304-x","title":"Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"CD68; Hazard ratio; Breast cancer; Medicine; Internal medicine; Adipose tissue; Immunohistochemistry; Confidence interval; Proportional hazards model; Cancer; Oncology; Endocrinology; Pathology","score_opus":0.00974374986901148,"score_gpt":0.27132533089478406,"score_spread":0.26158158102577256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186156042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958545,0.0001706512,0.000044777433,0.000013076976,0.0000025571474,0.0000018088226,0.000059150425,0.0000014036754,0.00012116121],"genre_scores_gemma":[0.9997789,0.000039429775,0.00003754763,0.000004257084,0.0000040365885,0.0000016627982,0.00006468583,4.4377813e-7,0.00006903366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990904,0.00001841201,0.000010636318,0.000022020116,0.000018238545,0.000021683916],"domain_scores_gemma":[0.99952555,0.00008410155,0.00021460872,0.000026673471,0.0000450481,0.000104030776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020281786,0.00012936522,0.00013733197,0.00048064027,0.00018314327,0.00028096564,0.00011860313,0.00022864115,0.0016555231],"category_scores_gemma":[0.0007201164,0.00013934186,0.00013600884,0.0003839131,0.00020024895,0.00021284595,0.00020707972,0.00027588685,0.0001821485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020527886,0.000013043671,0.9979995,0.000006460701,0.000013886359,0.00007134495,0.000017499062,0.000023583969,0.0007901283,0.000007577488,0.000035225166,0.00081639766],"study_design_scores_gemma":[0.0000066921257,0.00009032398,0.99851006,0.0000032170594,0.000013700977,0.0007340595,0.00012512658,0.00021709023,0.00015876877,0.000024339923,0.000114339615,0.0000022531676],"about_ca_topic_score_codex":0.0008132182,"about_ca_topic_score_gemma":0.0011755868,"teacher_disagreement_score":0.0016555231,"about_ca_system_score_codex":0.00009540518,"about_ca_system_score_gemma":0.00008312551,"threshold_uncertainty_score":0.005538285},"labels":[],"label_agreement":null},{"id":"W3186178212","doi":"10.1038/s41523-021-00305-w","title":"IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Weston Park Cancer Charity; Trent University; British Heart Foundation; Nottingham Trent University","keywords":"Medicine; Breast cancer; Bone metastasis; Metastasis; Immune system; Cancer research; Cytokine; Anakinra; Cancer; Oncology; Internal medicine; Immunology; Disease","score_opus":0.022761611898643598,"score_gpt":0.31744167291300474,"score_spread":0.2946800610143611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186178212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746236,0.015235335,0.0049787606,0.0006599684,0.00026539844,0.00019557968,0.0006103952,0.00026011924,0.0031708817],"genre_scores_gemma":[0.9882109,0.0059572617,0.0026962783,0.00031443933,0.00007411415,0.00021424337,0.0004185407,0.000039440183,0.0020747753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99972266,0.000038062903,0.00001559208,0.000047512473,0.000101546764,0.00007459536],"domain_scores_gemma":[0.9998933,0.000015721671,0.000031442756,0.000009884338,0.000009963287,0.000039562477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026493057,0.000430202,0.0006688037,0.00037151008,0.00012026405,0.00051198335,0.0002321107,0.00034181782,0.0012505185],"category_scores_gemma":[0.00013415674,0.00017637428,0.00035004024,0.00021149038,0.00029174698,0.00022284004,0.00031068898,0.001448123,0.00043097738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045848463,0.00032869482,0.00025549147,0.00021648381,0.0000217388,0.000060761904,0.000035087774,0.0003568595,0.9890344,0.00018873572,0.00032898237,0.008714257],"study_design_scores_gemma":[0.00042924882,0.011146261,0.008011788,0.00007452841,0.00021809775,0.0008523023,0.00011675334,0.0026581301,0.9538715,0.00042075137,0.02216767,0.000033028067],"about_ca_topic_score_codex":0.00022005028,"about_ca_topic_score_gemma":0.0006825403,"teacher_disagreement_score":0.0012505185,"about_ca_system_score_codex":0.00029694915,"about_ca_system_score_gemma":0.0002486816,"threshold_uncertainty_score":0.004183352},"labels":[],"label_agreement":null},{"id":"W3186622353","doi":"10.1038/s41523-021-00301-0","title":"Evaluation of multiple transcriptomic gene risk signatures in male breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Concordance; Oncology; Breast cancer; Medicine; Subtyping; Internal medicine; Cancer; Gene signature; Univariate analysis; Univariate; Gynecology; Gene; Multivariate analysis; Gene expression; Biology; Genetics; Multivariate statistics","score_opus":0.02990180125828365,"score_gpt":0.33546001534381364,"score_spread":0.30555821408552997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186622353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997658,0.00036445298,0.0010730032,0.00003270871,0.000003958662,0.00001462393,0.00047146156,0.000017048715,0.00036471133],"genre_scores_gemma":[0.9972,0.00016515187,0.0016099385,0.000034591147,0.0000074813383,0.00001945663,0.0006852474,0.0000058628025,0.0002723263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965966,0.00008909132,0.000020035295,0.00007139264,0.00011092333,0.00004889172],"domain_scores_gemma":[0.99962544,0.00011617007,0.00013928383,0.000029296889,0.00005614142,0.000033655906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047874745,0.00017334899,0.0002839743,0.00079517614,0.00016622001,0.00038632922,0.000113828835,0.00013514436,0.00067260244],"category_scores_gemma":[0.0007333299,0.00007694553,0.00021205917,0.00060953933,0.00014908848,0.00011005828,0.000249128,0.00016477657,0.0001430592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084926403,0.00009260198,0.81843424,0.000079564765,0.00014424819,0.00033403718,0.00018824567,0.0011084607,0.1434457,0.000091140755,0.00026152728,0.034971017],"study_design_scores_gemma":[0.0000132909245,0.0005209901,0.95940393,0.000009737824,0.00010388587,0.0010448112,0.00018111349,0.0031220275,0.03435272,0.00013038547,0.0011040495,0.000012944874],"about_ca_topic_score_codex":0.00057566614,"about_ca_topic_score_gemma":0.0011345159,"teacher_disagreement_score":0.00079517614,"about_ca_system_score_codex":0.00016630102,"about_ca_system_score_gemma":0.00015742455,"threshold_uncertainty_score":0.002531886},"labels":[],"label_agreement":null},{"id":"W3193416718","doi":"10.1038/s41523-021-00315-8","title":"Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society Research Institute; Fondation du cancer du sein du Québec; Cancer Research Society","keywords":"Homologous recombination; Proband; Breast cancer; Gene; Homologous chromosome; Genetics; Biology; Recombination; DNA repair; Cancer; Mutation","score_opus":0.0180938311625258,"score_gpt":0.28182242959528936,"score_spread":0.2637285984327636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193416718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98250407,0.0058907606,0.0020786144,0.00038412088,0.000038677892,0.000031687963,0.003998364,0.0002087741,0.0048649833],"genre_scores_gemma":[0.99449253,0.0013700475,0.0011501736,0.00009398654,0.00003641233,0.00002052754,0.0020425539,0.00003268045,0.0007610736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990872,0.00012510651,0.00007750237,0.00034837527,0.00024824514,0.000113574526],"domain_scores_gemma":[0.9982345,0.00082906743,0.0005141173,0.00021063525,0.00010342051,0.0001082373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047086834,0.0006830515,0.0006053498,0.001967225,0.00055920624,0.0007226404,0.0007480857,0.0005510734,0.01170216],"category_scores_gemma":[0.0031529253,0.00021737834,0.00038342297,0.0013907724,0.00039946588,0.00046416812,0.0004446304,0.00030848949,0.0012138243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044732052,0.00006501347,0.93182063,0.0001505316,0.00026846398,0.0048594587,0.00039754258,0.00041580238,0.016128022,0.0009634964,0.0014374763,0.04304622],"study_design_scores_gemma":[0.00003349618,0.0001272589,0.9512175,0.00010424217,0.0005861996,0.025972547,0.0004926403,0.0011247103,0.0046735485,0.0022200772,0.013424163,0.000023602415],"about_ca_topic_score_codex":0.0023974425,"about_ca_topic_score_gemma":0.0019141964,"teacher_disagreement_score":0.01170216,"about_ca_system_score_codex":0.00029768219,"about_ca_system_score_gemma":0.00034788798,"threshold_uncertainty_score":0.039147615},"labels":[],"label_agreement":null},{"id":"W3197447043","doi":"10.1038/s41523-021-00325-6","title":"Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Region Midtjylland; Novo Nordisk Fonden; Steno Diabetes Center Aarhus; Aarhus Universitet","keywords":"Triple-negative breast cancer; Meta-analysis; Overweight; Medicine; Breast cancer; Oncology; Cancer; Triple negative; Internal medicine; Obesity","score_opus":0.051448354866789045,"score_gpt":0.36366941953809534,"score_spread":0.3122210646713063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197447043","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038839367,0.99416405,0.000507216,0.00021146663,0.00012040929,0.00039833717,0.0005095293,0.000020929267,0.00018409072],"genre_scores_gemma":[0.10562538,0.8873735,0.0029190795,0.00081889075,0.00027053512,0.001799924,0.00087566196,0.000022572463,0.00029448036],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99295676,0.0030809257,0.0021727178,0.00064850715,0.0008436795,0.0002975467],"domain_scores_gemma":[0.9876774,0.008466946,0.0021067765,0.00039095888,0.0011536368,0.0002043675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011524873,0.0026141813,0.017903816,0.008336385,0.0007197144,0.0031300962,0.0019699717,0.0020938544,0.0029902689],"category_scores_gemma":[0.026189575,0.001761105,0.029707951,0.008326048,0.00058639696,0.0017667935,0.0015964053,0.001477466,0.00026500862],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010300066,0.000030391946,0.0040004514,0.57012635,0.41004336,0.00020231592,0.00011268182,0.0006042982,0.00026936494,0.00016180024,0.0007314341,0.012687492],"study_design_scores_gemma":[0.00037900748,0.00019565316,0.0037346936,0.049805414,0.94299847,0.00015840818,0.000049711,0.0002028647,0.000108820655,0.00020687374,0.0021323117,0.000027716245],"about_ca_topic_score_codex":0.006527096,"about_ca_topic_score_gemma":0.015982997,"teacher_disagreement_score":0.017903816,"about_ca_system_score_codex":0.00276287,"about_ca_system_score_gemma":0.004621178,"threshold_uncertainty_score":0.0609501},"labels":[],"label_agreement":null},{"id":"W3198037870","doi":"10.1038/s41523-021-00320-x","title":"Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Breast cancer; Tissue microarray; DNA-PKcs; Biomarker; Cancer research; Biology; Cancer; Immune system; DNA microarray; Immune checkpoint; Immunohistochemistry; Medicine; DNA damage; DNA; Gene; Gene expression; Immunotherapy; Immunology; Genetics","score_opus":0.015655547269751595,"score_gpt":0.29123154499439274,"score_spread":0.27557599772464114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198037870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998086,0.00061361404,0.00037653965,0.000043396834,0.0000057791967,0.0000069987527,0.00044783752,0.000011003675,0.0004088697],"genre_scores_gemma":[0.9986172,0.00015909609,0.00017909023,0.000020911677,0.0000073271763,0.000008875706,0.0007100667,0.0000039001948,0.00029351684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996865,0.00006040433,0.000035601086,0.000093183844,0.00007009404,0.00005424036],"domain_scores_gemma":[0.9992055,0.00016617228,0.0002972413,0.00010119598,0.00011776593,0.00011214265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007896959,0.00018002011,0.0003718804,0.0006207816,0.00024680354,0.0008039438,0.00022568602,0.00036266647,0.0011803056],"category_scores_gemma":[0.0014437964,0.00011306304,0.00018728706,0.0005422284,0.0002291409,0.0002624159,0.00037444258,0.00040839997,0.0004566873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009898782,0.000058605423,0.97062725,0.000043609372,0.0001006121,0.00008636328,0.000069605354,0.00020191462,0.019029848,0.00004430998,0.00013978628,0.008608269],"study_design_scores_gemma":[0.000006154816,0.0001501586,0.9945866,0.000008403255,0.00005667739,0.00034400597,0.000110306646,0.0004669909,0.00374306,0.00012110367,0.00040210094,0.0000044605395],"about_ca_topic_score_codex":0.00065236405,"about_ca_topic_score_gemma":0.0010601636,"teacher_disagreement_score":0.0011803056,"about_ca_system_score_codex":0.00027597285,"about_ca_system_score_gemma":0.00020798341,"threshold_uncertainty_score":0.0041763783},"labels":[],"label_agreement":null},{"id":"W3198768601","doi":"10.1038/s41523-021-00322-9","title":"Clinical consequences of BRCA2 hypomorphism","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya; Fundación Cellex; Agència de Gestió d'Ajuts Universitaris i de Recerca; Ministerio de Economía y Competitividad; Generalitat de Catalunya; European Commission; Fanconi Anemia Research Fund","keywords":"Fanconi anemia; RAD51; Missense mutation; Allele; Breast cancer; Cancer research; BRCA2 Protein; Biology; Ovarian cancer; DNA repair; Phenotype; Chemotherapy; DNA damage; Genetics; Cancer; Mutation; Germline mutation; DNA; Gene","score_opus":0.015509870257282326,"score_gpt":0.35314096221716623,"score_spread":0.3376310919598839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198768601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98893213,0.001659168,0.0019537504,0.0004795427,0.0000477955,0.00005446577,0.0006446205,0.0003075393,0.0059210598],"genre_scores_gemma":[0.99730384,0.0004354195,0.0004746666,0.00016406902,0.000013305702,0.000011446967,0.00020612846,0.000031216012,0.0013599581],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998733,0.000017856744,0.000009396312,0.000044675104,0.000031385323,0.000023378598],"domain_scores_gemma":[0.9998312,0.000037380058,0.000054812972,0.000012260137,0.000012891053,0.000051464584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009881793,0.00049466477,0.00023546607,0.0004061514,0.0002219922,0.00021441089,0.00014451912,0.00043539683,0.002465757],"category_scores_gemma":[0.00041006794,0.00010512248,0.000117924144,0.00022067978,0.0003242998,0.00009124664,0.00020793205,0.00041680867,0.0003537929],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008149488,0.00013087256,0.024880683,0.00014664316,0.000034927434,0.16155344,0.00013449459,0.00025649226,0.78299034,0.00079412677,0.0019405973,0.026322432],"study_design_scores_gemma":[0.000057591682,0.0007839698,0.13161965,0.000041187737,0.000081936596,0.68171465,0.0001447261,0.00070028467,0.17442396,0.00060137553,0.009802405,0.00002816646],"about_ca_topic_score_codex":0.00041045045,"about_ca_topic_score_gemma":0.00046444323,"teacher_disagreement_score":0.002465757,"about_ca_system_score_codex":0.00020871924,"about_ca_system_score_gemma":0.00015778914,"threshold_uncertainty_score":0.008248746},"labels":[],"label_agreement":null},{"id":"W3207569082","doi":"10.1038/s41523-021-00345-2","title":"Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Stromal cell; Cancer research; Oncology; Medicine; Lymphocytic infiltration; Androgen receptor; Estrogen receptor; Internal medicine; Pathology; Biology; Cancer; Prostate cancer","score_opus":0.01155565826883234,"score_gpt":0.26406708579937455,"score_spread":0.25251142753054223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207569082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41333386,0.005295738,0.3237265,0.0014863444,0.0007106113,0.0056731836,0.19874983,0.019442119,0.031581808],"genre_scores_gemma":[0.37030697,0.0010353657,0.46128303,0.0005149189,0.00019510427,0.0040152017,0.15116821,0.0027535532,0.00872769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623364,0.00065349264,0.0009156964,0.00071344775,0.0011323356,0.0003513584],"domain_scores_gemma":[0.9927649,0.0017890756,0.001432579,0.0013275674,0.0022425156,0.00044337512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004100513,0.0010446481,0.001262734,0.00941544,0.0012521305,0.0018391248,0.0012736006,0.0006005066,0.0051593394],"category_scores_gemma":[0.011806626,0.00044233992,0.0016064513,0.005998137,0.0003682116,0.0006749507,0.0017958148,0.0011154467,0.0031293598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028238883,0.00023478964,0.5308155,0.00147612,0.0012921776,0.00052857853,0.0010628367,0.003915977,0.028305206,0.0066650445,0.09188654,0.33099338],"study_design_scores_gemma":[0.0006230578,0.0006761745,0.67096406,0.00070045184,0.0011470425,0.004283682,0.0014830432,0.04307461,0.026156763,0.015585872,0.23506552,0.00023980526],"about_ca_topic_score_codex":0.013813119,"about_ca_topic_score_gemma":0.018725328,"teacher_disagreement_score":0.013813119,"about_ca_system_score_codex":0.0016163622,"about_ca_system_score_gemma":0.003366942,"threshold_uncertainty_score":0.027465403},"labels":[],"label_agreement":null},{"id":"W3214960410","doi":"10.1038/s41523-021-00346-1","title":"The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Université de Montréal; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Breast Cancer Foundation; National Center for Advancing Translational Sciences; Royal Australasian College of Physicians; National Health and Medical Research Council; Breast Cancer Research Foundation","keywords":"Oncology; Immunotherapy; Breast cancer; Medicine; Tumor-infiltrating lymphocytes; Biomarker; Internal medicine; Immune checkpoint; Cancer; Clinical Oncology; Triple-negative breast cancer; Biology","score_opus":0.0420120292087145,"score_gpt":0.3629201689834325,"score_spread":0.320908139774718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214960410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000979199,0.9978726,0.000055481043,0.0009652462,0.0004499104,0.0000038096643,0.000019259483,0.0000034500663,0.00053232576],"genre_scores_gemma":[0.000665662,0.99767035,0.00011002246,0.0008701601,0.00029697455,0.000005685483,0.000035713445,0.0000014863058,0.0003438781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972254,0.00005255611,0.000041385625,0.000052530406,0.00010289457,0.000028209384],"domain_scores_gemma":[0.9992398,0.00034794133,0.00006601661,0.000014907173,0.00027461603,0.000056848796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012447751,0.0006374539,0.00091898785,0.002275849,0.00025705766,0.0011471135,0.0005248054,0.0011234249,0.0014897309],"category_scores_gemma":[0.0017124213,0.00025077138,0.000685345,0.0022064627,0.00043877654,0.0014941137,0.0008074913,0.002416136,0.0009443158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013334981,0.000044301836,0.00032314402,0.013026028,0.000091624905,0.00017641617,0.000096454074,0.00026106584,0.0009224604,0.003060279,0.076419875,0.90544504],"study_design_scores_gemma":[0.000023097518,0.00010632633,0.0010844287,0.0058367047,0.00018719066,0.001122053,0.00006804113,0.000082181585,0.0004560154,0.0010714269,0.9899408,0.00002175484],"about_ca_topic_score_codex":0.0018771358,"about_ca_topic_score_gemma":0.0021146697,"teacher_disagreement_score":0.002275849,"about_ca_system_score_codex":0.00080200454,"about_ca_system_score_gemma":0.0018969282,"threshold_uncertainty_score":0.006583035},"labels":[],"label_agreement":null},{"id":"W3215126804","doi":"10.1038/s41523-021-00355-0","title":"Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Sleep and related disorders","field":"Psychology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"H2020 European Research Council; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Patient-Centered Outcomes Research Institute","keywords":"Insomnia; Medicine; Acupuncture; Randomized controlled trial; Physical therapy; Cancer pain; Quality of life (healthcare); Cognitive behavioral therapy for insomnia; Cognitive behavioral therapy; Internal medicine; Cancer; Psychiatry; Alternative medicine","score_opus":0.059138803911797454,"score_gpt":0.40631886022434943,"score_spread":0.347180056312552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215126804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968597,0.014824648,0.002274777,0.0007206885,0.0005762589,0.010834882,0.0007155672,0.00014072814,0.0013154292],"genre_scores_gemma":[0.9820846,0.0031121292,0.003460808,0.00058853906,0.00033332373,0.009227928,0.00035021405,0.00002126807,0.00082125666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98460674,0.01256869,0.0009853491,0.00065332634,0.000704564,0.0004813042],"domain_scores_gemma":[0.9855424,0.010385128,0.0020213057,0.0006841345,0.00061027065,0.00075670367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014498762,0.0017431015,0.00546388,0.0009594708,0.0005340521,0.0013116341,0.0009882197,0.0020869959,0.0038816656],"category_scores_gemma":[0.01974044,0.0007066338,0.0074585145,0.0010097033,0.0011659724,0.0014869516,0.00084171665,0.0022510998,0.00033742195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97552127,0.002775939,0.0009960188,0.0013501947,0.009311129,0.000039027484,0.000085714884,0.00029659146,0.00055696856,0.000103984,0.00017764348,0.008785575],"study_design_scores_gemma":[0.88639843,0.09686884,0.0036341788,0.00018313533,0.010789323,0.00003325192,0.00007392699,0.0011618824,0.00025354102,0.00030210716,0.00027644748,0.000024961031],"about_ca_topic_score_codex":0.0013087703,"about_ca_topic_score_gemma":0.0024348637,"teacher_disagreement_score":0.014498762,"about_ca_system_score_codex":0.0014068178,"about_ca_system_score_gemma":0.0021604698,"threshold_uncertainty_score":0.07667768},"labels":[],"label_agreement":null},{"id":"W3216265150","doi":"10.1038/s41523-021-00354-1","title":"Mammographic texture features associated with contralateral breast cancer in the WECARE Study","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of Allergy and Infectious Diseases; U.S. Department of Health and Human Services; Cancer Australia; National Cancer Institute; Cure Cancer Australia Foundation; Cancer Council Victoria","keywords":"Medicine; Breast cancer; Confounding; MAMMOGRAPHIC DENSITY; Mammography; Texture (cosmology); Odds ratio; Cancer; Internal medicine; Artificial intelligence; Computer science; Image (mathematics)","score_opus":0.005498334503839506,"score_gpt":0.2790828574298052,"score_spread":0.2735845229259657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216265150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939764,0.0001666057,0.000054514272,0.000023887995,0.0000037474097,0.0000049861856,0.00010726817,0.0000016037968,0.00023977339],"genre_scores_gemma":[0.9997316,0.000042546442,0.000034874738,0.000012086585,0.000004336059,0.0000027497765,0.00010313659,0.0000012395384,0.00006745395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954116,0.000115969786,0.000046067784,0.000103463884,0.00012811566,0.00006521907],"domain_scores_gemma":[0.99897087,0.00015233587,0.00050683704,0.00013642113,0.000103024904,0.00013051232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043134874,0.00019340136,0.00025141778,0.00076378783,0.00029520047,0.00059703283,0.00021604725,0.00026522725,0.0012115164],"category_scores_gemma":[0.0031538308,0.00019721735,0.00033246446,0.00068765355,0.00025517595,0.00024132918,0.00038642387,0.00036168657,0.00007637809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017768008,0.000023856477,0.9979982,0.0000055609094,0.00005492631,0.00010292174,0.00006551044,0.000014718561,0.00036688463,0.000031207368,0.00008625412,0.0010722826],"study_design_scores_gemma":[0.000009166641,0.000037117174,0.99927896,0.0000035406194,0.000029335904,0.0002694111,0.0000749468,0.00009020614,0.00008279952,0.00002494081,0.00009693233,0.0000026276791],"about_ca_topic_score_codex":0.010718378,"about_ca_topic_score_gemma":0.0116296,"teacher_disagreement_score":0.010718378,"about_ca_system_score_codex":0.00023725674,"about_ca_system_score_gemma":0.0002104522,"threshold_uncertainty_score":0.021311998},"labels":[],"label_agreement":null},{"id":"W4220913811","doi":"10.1038/s41523-022-00405-1","title":"Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Breast Cancer Foundation","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; BRCA mutation; Chemotherapy; Metastatic breast cancer; PARP inhibitor; Cancer; Olaparib; Proportional hazards model; Meta-analysis; Clinical trial; Poly ADP ribose polymerase; Confidence interval; Polymerase; Biology","score_opus":0.010978979176223775,"score_gpt":0.28127023104745524,"score_spread":0.2702912518712315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220913811","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08239109,0.91517407,0.00033629418,0.00058021204,0.00013737548,0.000069409885,0.00077665393,0.000013168497,0.0005217521],"genre_scores_gemma":[0.81141436,0.18421203,0.000782542,0.0011552853,0.0004771375,0.00025010126,0.0012626516,0.00002464351,0.00042119608],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9936174,0.0028525225,0.001945548,0.00080156996,0.00060308905,0.00017987863],"domain_scores_gemma":[0.9748403,0.018213142,0.005054559,0.00068259327,0.0009558235,0.00025362108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010759654,0.0008398636,0.005683042,0.0021596907,0.00025785886,0.0017584078,0.00085881795,0.0016512783,0.0016321315],"category_scores_gemma":[0.022625728,0.0006625673,0.012507467,0.004537749,0.00046601507,0.0010129494,0.0005609708,0.0018166897,0.00016113443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027703436,0.00019424532,0.21312605,0.107685,0.60640055,0.00032891423,0.00020371552,0.0015912635,0.00089451065,0.00021492303,0.0018481793,0.03980923],"study_design_scores_gemma":[0.0037737216,0.002042448,0.28413886,0.009199334,0.6939038,0.00052485376,0.00014173693,0.0010582453,0.00048213865,0.0007892977,0.0038675868,0.00007799804],"about_ca_topic_score_codex":0.0018525284,"about_ca_topic_score_gemma":0.0027937829,"teacher_disagreement_score":0.010759654,"about_ca_system_score_codex":0.00072524516,"about_ca_system_score_gemma":0.00051588245,"threshold_uncertainty_score":0.056903183},"labels":[],"label_agreement":null},{"id":"W4225270990","doi":"10.1038/s41523-022-00425-x","title":"Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Cancer Research UK; BC Cancer Agency; QIMR Berghofer Medical Research Institute; Metro North Hospital and Health Service; Department of Foreign Affairs and Trade, Australian Government; Cancer Research Institute","keywords":"SOX10; Biology; Triple-negative breast cancer; Reprogramming; Cancer research; Breast cancer; Phenotype; Neural crest; Genetics; Cancer; Gene","score_opus":0.009202576760837917,"score_gpt":0.257375750146791,"score_spread":0.24817317338595307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225270990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985738,0.00011630667,0.00097068434,0.000009550294,0.0000013961845,0.0000031263137,0.00010289511,0.000019079349,0.00020305807],"genre_scores_gemma":[0.9990907,0.00006295928,0.00043692696,0.000005537192,5.368169e-7,0.0000045145084,0.00017364878,0.000003299397,0.00022181988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990463,0.00001974698,0.0000048773827,0.000024155172,0.000027673263,0.000018956176],"domain_scores_gemma":[0.99990964,0.000023370552,0.000030137702,0.000011354326,0.000009978731,0.00001551717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013203506,0.000115328825,0.0001778867,0.00021507406,0.00010119042,0.00023965328,0.0000827657,0.00010241591,0.0005203873],"category_scores_gemma":[0.00027556848,0.00012071041,0.00018360783,0.00020545992,0.00015208957,0.00009143373,0.00017631827,0.00016709688,0.000106536194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029214536,0.000021583965,0.048061956,0.0000470088,0.00004114042,0.00015978732,0.000118107324,0.0016710663,0.9422349,0.00017864381,0.000071162816,0.007102556],"study_design_scores_gemma":[0.00000754003,0.00018723175,0.81860673,0.00000894636,0.000053421078,0.00056137366,0.00026323204,0.024185933,0.15455377,0.00047775658,0.0010826242,0.000011515015],"about_ca_topic_score_codex":0.001955143,"about_ca_topic_score_gemma":0.0036192033,"teacher_disagreement_score":0.001955143,"about_ca_system_score_codex":0.00028217633,"about_ca_system_score_gemma":0.0001401316,"threshold_uncertainty_score":0.0038875341},"labels":[],"label_agreement":null},{"id":"W4281762255","doi":"10.1038/s41523-022-00435-9","title":"Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; NIHR Cambridge Biomedical Research Centre; BC Cancer Agency; Fundação para a Ciência e a Tecnologia; Centro de Investigação em Biomedicina; Centro de Investigação em Tecnologias e Serviços de Saúde; European Commission; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Allele; Breast cancer; Missense mutation; Cancer research; Mutant; Gene; Biology; Estrogen receptor; Cancer; Medicine; Oncology; Genetics; Mutation","score_opus":0.0084076767347095,"score_gpt":0.26466906326024414,"score_spread":0.25626138652553465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281762255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653256,0.0007377864,0.0009779863,0.00009364126,0.000010127859,0.000007159598,0.00048092907,0.00002684764,0.0011329962],"genre_scores_gemma":[0.99910045,0.00015169973,0.00025598708,0.000026426023,0.0000073242795,0.000003281558,0.00030826736,0.0000074112654,0.00013918625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911004,0.000198866,0.000105072926,0.00024778818,0.00022973205,0.00010843228],"domain_scores_gemma":[0.99904686,0.00019443494,0.0004967324,0.000105468745,0.00007523443,0.000081154554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007788159,0.00018589348,0.00028270602,0.0011800437,0.0002901423,0.00067340455,0.00022530633,0.0002493792,0.0014169761],"category_scores_gemma":[0.002112419,0.00012496875,0.00019808408,0.0011856914,0.00032141572,0.00020393463,0.00044426642,0.00026942394,0.00026071238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065593875,0.000029080345,0.93443614,0.000059736176,0.00022074235,0.0010794078,0.000083522034,0.00016501428,0.04450042,0.0002792961,0.00036383574,0.0181268],"study_design_scores_gemma":[0.000008412101,0.000081806225,0.98551613,0.000009219997,0.00012246535,0.0050839856,0.00013706618,0.00038266028,0.006585447,0.0005257772,0.0015370224,0.000009890198],"about_ca_topic_score_codex":0.0009222557,"about_ca_topic_score_gemma":0.0019915379,"teacher_disagreement_score":0.0014169761,"about_ca_system_score_codex":0.00021531455,"about_ca_system_score_gemma":0.00017740532,"threshold_uncertainty_score":0.004740298},"labels":[],"label_agreement":null},{"id":"W4283775775","doi":"10.1038/s41523-022-00442-w","title":"The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"Congressionally Directed Medical Research Programs; Canadian Glycomics Network; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC; Susan G. Komen; Government of Canada; U.S. Department of Defense","keywords":"Polysialic acid; Breast cancer; Cancer research; Cancer; Medicine; Internal medicine; Oncology; Biology; Cell; Neural cell adhesion molecule; Genetics; Cell adhesion","score_opus":0.007499917206947022,"score_gpt":0.25585511794032423,"score_spread":0.24835520073337722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283775775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975968,0.0009969153,0.00013221429,0.000039055416,0.00001197579,0.000005203065,0.00007745055,0.000004450324,0.0011359025],"genre_scores_gemma":[0.9995283,0.00013580985,0.000055092158,0.000013099732,0.000010635665,0.0000037807185,0.00008598256,0.0000011643007,0.00016623831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978334,0.00004435013,0.000028179962,0.000040806473,0.000041759435,0.00006170951],"domain_scores_gemma":[0.9995535,0.00010731928,0.00013189876,0.000035408913,0.000060550683,0.00011127314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027704478,0.0001310423,0.00020625662,0.0005870711,0.00017046544,0.0004089442,0.00015928192,0.0003018959,0.00091941835],"category_scores_gemma":[0.0012152079,0.00006672168,0.00013654512,0.0004809684,0.0002343842,0.00028122746,0.0002708748,0.0002415755,0.0002206495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001183577,0.000027653843,0.98142254,0.00002393478,0.000035546218,0.00047397806,0.00007136874,0.00008591384,0.0079715755,0.00006895778,0.00010404651,0.008530934],"study_design_scores_gemma":[0.000021321352,0.00017368449,0.9923132,0.000013107722,0.000053654803,0.002405317,0.00031954815,0.0006209727,0.0029855212,0.00019005904,0.00089554145,0.000008028584],"about_ca_topic_score_codex":0.00043579048,"about_ca_topic_score_gemma":0.000504604,"teacher_disagreement_score":0.00091941835,"about_ca_system_score_codex":0.00020229197,"about_ca_system_score_gemma":0.00009237795,"threshold_uncertainty_score":0.0030757785},"labels":[],"label_agreement":null},{"id":"W4285992942","doi":"10.1038/s41523-022-00452-8","title":"PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; Amis de l'Institut Bordet; Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro; National Institute for Health and Care Research; American Society of Clinical Oncology; GlaxoSmithKline","keywords":"Lapatinib; Trastuzumab; Medicine; Internal medicine; Breast cancer; Oncology; Stage (stratigraphy); Chemotherapy; Population; Cancer","score_opus":0.019051291407503723,"score_gpt":0.31597203856608413,"score_spread":0.2969207471585804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285992942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994764,0.0013710038,0.0018546681,0.00015956425,0.000036215835,0.000012138285,0.0010992329,0.00002793173,0.00067521574],"genre_scores_gemma":[0.9981096,0.00018289434,0.00038380708,0.000070519985,0.000040617557,0.0000065994377,0.001042114,0.000009278499,0.00015466836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984397,0.0008754856,0.0001307952,0.00023920639,0.00021279839,0.00010193338],"domain_scores_gemma":[0.9906911,0.006447029,0.001486225,0.00068371784,0.00044922243,0.00024255467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004635173,0.0005782471,0.00069951813,0.0006885002,0.00018903828,0.000872188,0.0002936437,0.00032492678,0.0008574671],"category_scores_gemma":[0.009474663,0.00016151067,0.0007750644,0.0005732586,0.0002177563,0.0005709227,0.0006579897,0.0005926814,0.00029777584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006505619,0.000015114795,0.9886645,0.000045031844,0.00018405427,0.00003154123,0.00003937709,0.0012457364,0.00027254352,0.000039461145,0.00029631046,0.008515711],"study_design_scores_gemma":[0.000034864282,0.00045259413,0.98242754,0.000046986126,0.00040792,0.0005466502,0.00011081157,0.012472314,0.0010167537,0.0005349419,0.0019290566,0.000019614135],"about_ca_topic_score_codex":0.0012488122,"about_ca_topic_score_gemma":0.0023026492,"teacher_disagreement_score":0.004635173,"about_ca_system_score_codex":0.0002276579,"about_ca_system_score_gemma":0.00033385563,"threshold_uncertainty_score":0.024513423},"labels":[],"label_agreement":null},{"id":"W4293047601","doi":"10.1038/s41523-022-00458-2","title":"MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Government of Canada; U.S. Department of Health and Human Services","keywords":"Breast cancer; Medicine; Tamoxifen; Body mass index; Breast MRI; Cancer; Poisson regression; Magnetic resonance imaging; Cross-sectional study; Confidence interval; Risk factor; Oncology; Gynecology; Internal medicine; Radiology; Mammography; Population; Pathology","score_opus":0.018370807905552972,"score_gpt":0.3159501581145901,"score_spread":0.29757935020903714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293047601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993224,0.00025997835,0.00006126248,0.0000239352,0.0000029701303,0.000013150626,0.00014367655,0.0000014234134,0.00017118029],"genre_scores_gemma":[0.99926823,0.00015713857,0.0001367644,0.000057470654,0.000008509329,0.000019788611,0.00016537687,0.0000013931121,0.0001854924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966407,0.00012268058,0.000030663567,0.00007697961,0.00006220103,0.000043479005],"domain_scores_gemma":[0.9990029,0.0002560944,0.0003021152,0.000101495054,0.00012328745,0.00021421685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092338957,0.00021548438,0.00028947616,0.00049643114,0.00040434557,0.00043966208,0.00022471121,0.00059264165,0.0010083147],"category_scores_gemma":[0.0020523642,0.0006653811,0.00031345323,0.00066182425,0.00022993206,0.00038581764,0.00030197966,0.00055993634,0.0002510757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010518229,0.000088327404,0.99890125,0.000008886914,0.000052751508,0.000053587028,0.00013258377,0.000009150845,0.00023547011,0.0000050164967,0.00002852662,0.00037922038],"study_design_scores_gemma":[0.0000061924707,0.00018262974,0.99932194,0.0000028401666,0.000028818476,0.00019437443,0.00012807081,0.000032826,0.00002762835,0.0000036968895,0.00006942872,0.0000015533575],"about_ca_topic_score_codex":0.0050421716,"about_ca_topic_score_gemma":0.0067402027,"teacher_disagreement_score":0.0050421716,"about_ca_system_score_codex":0.00018722477,"about_ca_system_score_gemma":0.0002136558,"threshold_uncertainty_score":0.01002562},"labels":[],"label_agreement":null},{"id":"W4308569225","doi":"10.1038/s41523-022-00488-w","title":"Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"AI in cancer detection","field":"Computer Science","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Innovative Medicines Initiative; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Commission; Puma Biotechnology; AstraZeneca; Myriad Genetics; European Federation of Pharmaceutical Industries and Associations; Daiichi Sankyo Europe; Horizon 2020 Framework Programme; Knut och Alice Wallenbergs Stiftelse; Bristol-Myers Squibb","keywords":"Pleomorphism (cytology); Grading (engineering); Breast cancer; Limiting; Artificial intelligence; Pathology; Radiology; Medicine; Computer science; Cancer; Biology; Internal medicine","score_opus":0.011400631360581837,"score_gpt":0.2521539765656102,"score_spread":0.2407533452050284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308569225","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32626075,0.0030732933,0.64431256,0.0010206031,0.00019563275,0.00024897532,0.0016253464,0.017300837,0.005962051],"genre_scores_gemma":[0.8263126,0.00042152908,0.16472636,0.0003948889,0.000052456784,0.00018194543,0.0030274251,0.00023468977,0.004648008],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993104,0.0001974139,0.00003442544,0.00018466006,0.00014551474,0.00012758865],"domain_scores_gemma":[0.998995,0.0004475837,0.00009017363,0.00015870747,0.00024446577,0.00006407325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014203888,0.0009899649,0.0006675037,0.0007317851,0.00038103212,0.0008618449,0.001471612,0.0011993347,0.0015891221],"category_scores_gemma":[0.0033230614,0.0004500853,0.0005800126,0.0005941304,0.00038602145,0.0007729465,0.001210374,0.0011031406,0.00080623303],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042435975,0.00038749282,0.0060896794,0.0002317783,0.00015550148,0.00019130456,0.00022968111,0.38244057,0.022766938,0.002216582,0.01330318,0.57156295],"study_design_scores_gemma":[0.000009036037,0.000034762837,0.00096859824,0.000011586092,0.0000069702864,0.000026738753,0.000016161704,0.9937696,0.0031265917,0.0013054141,0.00071731664,0.000007257143],"about_ca_topic_score_codex":0.010816153,"about_ca_topic_score_gemma":0.013011835,"teacher_disagreement_score":0.010816153,"about_ca_system_score_codex":0.0011727214,"about_ca_system_score_gemma":0.0011090422,"threshold_uncertainty_score":0.021506429},"labels":[],"label_agreement":null},{"id":"W4376630874","doi":"10.1038/s41523-023-00546-x","title":"PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants","year":2023,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Syöpäsäätiö; European Commission; Fondation du cancer du sein du Québec; National Cancer Institute; National Institutes of Health; Cancer Research UK; Government of Canada; Wellcome Trust; Canadian Institutes of Health Research; Sigrid Juséliuksen Säätiö; Genome Canada","keywords":"Breast cancer; Oncology; Internal medicine; Medicine; Cancer","score_opus":0.015006743225559852,"score_gpt":0.26973631242294754,"score_spread":0.2547295691973877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376630874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703985,0.00016979506,0.0012563614,0.00010809054,0.000014854536,0.000013056754,0.00055008044,0.000026338445,0.00082156644],"genre_scores_gemma":[0.998606,0.000035496876,0.00050180673,0.000022419477,0.000016942648,0.000008137968,0.0006209263,0.0000127429375,0.00017553344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980599,0.001105361,0.00010329775,0.00024708812,0.00031010094,0.0001743054],"domain_scores_gemma":[0.9906076,0.005751556,0.0014645717,0.0010893206,0.0005691795,0.0005177592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059653507,0.0007439205,0.0006080522,0.0016618947,0.0004015243,0.00094885135,0.0005469113,0.0006139966,0.0015463798],"category_scores_gemma":[0.02103655,0.00021356964,0.00080642436,0.00068412046,0.0005241652,0.0005472667,0.0010334192,0.0006357436,0.00055654143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004568779,0.000021490563,0.99424464,0.000006757767,0.00010961353,0.000057700327,0.00003878641,0.0010122363,0.00015654179,0.00005462796,0.00014110902,0.0036996068],"study_design_scores_gemma":[0.000054721142,0.00074748514,0.9614171,0.00002262508,0.00028909193,0.0009023596,0.00015605068,0.033414993,0.0011478787,0.0011377365,0.0006770967,0.000032838525],"about_ca_topic_score_codex":0.001749199,"about_ca_topic_score_gemma":0.0022756562,"teacher_disagreement_score":0.0059653507,"about_ca_system_score_codex":0.00039698617,"about_ca_system_score_gemma":0.0005937724,"threshold_uncertainty_score":0.031548202},"labels":[],"label_agreement":null},{"id":"W4389733405","doi":"10.1038/s41523-023-00591-6","title":"Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer","year":2023,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Breast cancer; Adjuvant; Adjuvant therapy; Oncology; Internal medicine; Stage (stratigraphy); Clinical trial; Radiation therapy; Incidence (geometry); Disease; Cancer; Gynecology","score_opus":0.006606687996877802,"score_gpt":0.25102714783786995,"score_spread":0.24442045984099214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389733405","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3353222,0.644748,0.0012425613,0.010518763,0.0007372994,0.00046466402,0.00067184813,0.000012562224,0.0062821186],"genre_scores_gemma":[0.8066952,0.18331651,0.0028594001,0.0050124917,0.00053892646,0.00042405765,0.00054275565,0.000005257579,0.0006054897],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998686,0.0009773364,0.0001481124,0.00005260938,0.00008906229,0.00004687478],"domain_scores_gemma":[0.99810886,0.0009970218,0.00054174237,0.00006297285,0.00015930606,0.0001300367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034796607,0.00014098173,0.00084419624,0.00028625468,0.0001518538,0.00062788423,0.00020688631,0.0004152455,0.0010665358],"category_scores_gemma":[0.008201811,0.00008761229,0.00048201572,0.0004997915,0.00017578497,0.0004986366,0.00024077894,0.0005446959,0.00018972773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033736292,0.0026968797,0.10700343,0.011275033,0.0021135486,0.00021434002,0.00048276066,0.0013614526,0.0034271404,0.0016008157,0.0068111494,0.82927716],"study_design_scores_gemma":[0.021961743,0.0898757,0.6208298,0.039569132,0.015241973,0.0016805099,0.00231005,0.0019038859,0.0060709864,0.0146483965,0.18577395,0.0001338608],"about_ca_topic_score_codex":0.0009523795,"about_ca_topic_score_gemma":0.0027704372,"teacher_disagreement_score":0.0034796607,"about_ca_system_score_codex":0.0004277299,"about_ca_system_score_gemma":0.0011180845,"threshold_uncertainty_score":0.018402398},"labels":[],"label_agreement":null},{"id":"W4390607200","doi":"10.1038/s41523-023-00607-1","title":"Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"BC Cancer Foundation; Canadian Institutes of Health Research; Susan G. Komen; Government of Canada; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Liquid biopsy; Oncology; Biopsy; Internal medicine; Neoadjuvant therapy; Circulating tumor DNA; Minimal residual disease; Pathology; Cancer","score_opus":0.008582745815151772,"score_gpt":0.3189100114348784,"score_spread":0.3103272656197266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390607200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470997,0.0019609537,0.002168871,0.00007743114,0.000018266319,0.000023312989,0.0001654726,0.000038576865,0.0008371748],"genre_scores_gemma":[0.9978218,0.0003097471,0.0014423458,0.000036734207,0.000012005045,0.000010528262,0.00011409497,0.0000036953445,0.0002490633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946254,0.00023629099,0.000036446145,0.000102078,0.00011715394,0.00004550119],"domain_scores_gemma":[0.99922335,0.00039511715,0.0001636629,0.000038314494,0.00009955639,0.000079973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008054237,0.0002198477,0.00037918423,0.00094742264,0.00012612724,0.0004903572,0.00020922693,0.00031920208,0.00081977114],"category_scores_gemma":[0.0016389124,0.00011252311,0.000103393155,0.0004086839,0.00019122753,0.00019250244,0.00018898513,0.00029456368,0.00024505876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021695255,0.00015041168,0.799374,0.0001659481,0.00007219213,0.000696294,0.00025467773,0.0005260589,0.14234278,0.00009582428,0.00030001844,0.053852342],"study_design_scores_gemma":[0.00005279726,0.002879992,0.9007761,0.00006180053,0.00016454291,0.006919407,0.0004179508,0.008190903,0.07802727,0.0003169549,0.0021647133,0.000027650533],"about_ca_topic_score_codex":0.0006748668,"about_ca_topic_score_gemma":0.001221748,"teacher_disagreement_score":0.00094742264,"about_ca_system_score_codex":0.00015165252,"about_ca_system_score_gemma":0.00015602088,"threshold_uncertainty_score":0.0042595267},"labels":[],"label_agreement":null},{"id":"W4393318831","doi":"10.1038/s41523-024-00629-3","title":"Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; George M. Eisenberg Foundation for Charities; Breast Cancer Research Foundation","keywords":"Medicine; Triple-negative breast cancer; Oncology; Internal medicine; Cohort; Breast cancer; Stage (stratigraphy); Cancer; Biology","score_opus":0.014489536226999,"score_gpt":0.3081748325583574,"score_spread":0.2936852963313584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393318831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948126,0.00016332092,0.00008852142,0.0000086254995,0.0000014389602,0.0000024046672,0.00010393494,0.000004260194,0.00014634574],"genre_scores_gemma":[0.99949837,0.000055656717,0.000059504702,0.0000038915373,0.00000461426,0.0000025936358,0.00027625836,0.0000011965403,0.00009782778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988437,0.00003049291,0.0000103420225,0.000034758403,0.000025867277,0.000014160412],"domain_scores_gemma":[0.99952173,0.00011510689,0.00021901623,0.000048740018,0.000057483692,0.000037949827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021701967,0.00014314776,0.00018690067,0.00035909947,0.00010370825,0.00030176583,0.00013442386,0.00014592183,0.00070248963],"category_scores_gemma":[0.0011779334,0.000114923736,0.00013811678,0.00030137337,0.00013218357,0.0001114886,0.00017865383,0.00016432689,0.00008681383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046860485,0.000027939743,0.9874329,0.000019464722,0.00005782705,0.000086969274,0.000038526043,0.0004896974,0.0024081154,0.000014203872,0.00017156644,0.008784147],"study_design_scores_gemma":[0.000007636171,0.00005411715,0.99857485,0.0000021568717,0.000018144165,0.00012654094,0.00002048984,0.00084731646,0.00022423171,0.00001639811,0.00010628586,0.0000018315855],"about_ca_topic_score_codex":0.0030848957,"about_ca_topic_score_gemma":0.0052663824,"teacher_disagreement_score":0.0030848957,"about_ca_system_score_codex":0.00019819403,"about_ca_system_score_gemma":0.00009245445,"threshold_uncertainty_score":0.0061338544},"labels":[],"label_agreement":null},{"id":"W4399806930","doi":"10.1038/s41523-024-00653-3","title":"Use of ctDNA in early breast cancer: analytical validity and clinical potential","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Svenska Sällskapet för Medicinsk Forskning","keywords":"Breast cancer; Circulating tumor DNA; Medicine; Oncology; Internal medicine; Clinical trial; Cancer; Minimal residual disease; Clinical Practice; Family medicine","score_opus":0.027612222489792775,"score_gpt":0.3205653539150176,"score_spread":0.29295313142522483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399806930","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16158801,0.7630252,0.046109345,0.009344118,0.0013988233,0.00027545702,0.0015438488,0.00030657,0.016408518],"genre_scores_gemma":[0.7659234,0.17101102,0.05018562,0.0046660104,0.002002706,0.00031403717,0.0016036965,0.00015049889,0.0041430676],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9824761,0.007317683,0.001100292,0.0023420313,0.006308108,0.00045573097],"domain_scores_gemma":[0.932688,0.04840348,0.008101964,0.0024906436,0.0075207558,0.00079513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02147817,0.0011480313,0.0011768624,0.0040176976,0.00045140547,0.0036669963,0.0013288416,0.0024884262,0.0015694286],"category_scores_gemma":[0.053784292,0.00057672634,0.00066506816,0.0028644633,0.0029885436,0.0015051558,0.0012149347,0.0020345324,0.0011844069],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024220776,0.00025507822,0.43599293,0.0038588038,0.00057729875,0.0009494223,0.0009244747,0.0015243602,0.032321513,0.0049350522,0.0038682767,0.51237065],"study_design_scores_gemma":[0.00027672554,0.005974739,0.51396596,0.009277234,0.0021411898,0.033053074,0.002963131,0.016505202,0.18254426,0.029149117,0.20353319,0.0006161897],"about_ca_topic_score_codex":0.0014591154,"about_ca_topic_score_gemma":0.0017109774,"teacher_disagreement_score":0.02147817,"about_ca_system_score_codex":0.0010673103,"about_ca_system_score_gemma":0.0014037958,"threshold_uncertainty_score":0.11358881},"labels":[],"label_agreement":null},{"id":"W4402494964","doi":"10.1038/s41523-024-00679-7","title":"Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Breast Cancer Foundation; Breast Cancer Research Foundation","keywords":"Pembrolizumab; Oncology; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Immunotherapy; Cancer","score_opus":0.008130626764051447,"score_gpt":0.27269681275941676,"score_spread":0.2645661859953653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402494964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97527426,0.008900498,0.0012720706,0.0013631404,0.00038100948,0.004515249,0.004825549,0.00010618735,0.0033620445],"genre_scores_gemma":[0.98482555,0.0030459713,0.0012155504,0.0020148999,0.00024457555,0.002982952,0.004503973,0.0000224036,0.0011441254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982382,0.0010865906,0.00016186075,0.00021581176,0.00015421679,0.00014332753],"domain_scores_gemma":[0.9983789,0.00043158492,0.0005185879,0.00016352086,0.00013365326,0.0003738522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056723603,0.001043997,0.0020016076,0.00026053123,0.00032095425,0.0007946623,0.0005965465,0.0008815889,0.0033472374],"category_scores_gemma":[0.002910625,0.00041297878,0.0024502757,0.00053028885,0.0006631884,0.0007967941,0.00042761536,0.0022676187,0.0005150884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93640614,0.007515162,0.00816372,0.0014497276,0.005607973,0.00008815599,0.00014106753,0.0007597858,0.0044937306,0.00024671812,0.003627782,0.031500023],"study_design_scores_gemma":[0.8153471,0.1204142,0.0483002,0.00019706771,0.008402058,0.00018588055,0.00010736439,0.0008373369,0.0011215678,0.0004388953,0.0045973444,0.00005096358],"about_ca_topic_score_codex":0.0008764242,"about_ca_topic_score_gemma":0.002416152,"teacher_disagreement_score":0.0056723603,"about_ca_system_score_codex":0.00083322474,"about_ca_system_score_gemma":0.0014644391,"threshold_uncertainty_score":0.02999872},"labels":[],"label_agreement":null},{"id":"W4407538000","doi":"10.1038/s41523-025-00720-3","title":"A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services","keywords":"Invasive lobular carcinoma; Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Cohort; Invasive ductal carcinoma","score_opus":0.013176440605504111,"score_gpt":0.3105113585715858,"score_spread":0.2973349179660817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407538000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755225,0.0154215805,0.0032378808,0.000079774254,0.000058263762,0.00008797658,0.0048052925,0.00005372687,0.00073295186],"genre_scores_gemma":[0.995697,0.00073983957,0.0006616537,0.000034054516,0.00004087602,0.00006519933,0.0025486653,0.000012865228,0.00019990322],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948249,0.0029195403,0.000513502,0.0010123004,0.00046254756,0.00026722855],"domain_scores_gemma":[0.9924273,0.0031682842,0.0015498595,0.0019929495,0.00061174994,0.00024984378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007762545,0.0006872896,0.0022962366,0.0019616494,0.00025746948,0.0011905556,0.00058111077,0.00056843745,0.0010153992],"category_scores_gemma":[0.012296714,0.00039833935,0.004271821,0.0024214147,0.00020057762,0.00038323132,0.0007533622,0.00034562533,0.00016662592],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010567079,0.000062497944,0.86581033,0.0007489169,0.103677176,0.00021400086,0.00012833338,0.0013673916,0.0019183385,0.00012587076,0.00085258094,0.014527511],"study_design_scores_gemma":[0.00043761116,0.0015637808,0.939146,0.00009251166,0.052985787,0.00029118097,0.0001311552,0.0027964998,0.0006140559,0.00017824626,0.0017326297,0.000030414669],"about_ca_topic_score_codex":0.0052988906,"about_ca_topic_score_gemma":0.0058259577,"teacher_disagreement_score":0.007762545,"about_ca_system_score_codex":0.00047662805,"about_ca_system_score_gemma":0.00048334297,"threshold_uncertainty_score":0.04105276},"labels":[],"label_agreement":null},{"id":"W4407752195","doi":"10.1038/s41523-025-00733-y","title":"Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Queen's University","funders":"National Cancer Institute; National Medical Research Council; Canadian Institutes of Health Research; Deutsche Krebshilfe; National Institute of General Medical Sciences; National Institute for Health and Care Research; Bundesministerium für Bildung und Forschung; Government of Canada; Deutsche Forschungsgemeinschaft; Department of Health and Social Care; Canadian Cancer Society Research Institute; National Institutes of Health; Ovarian Cancer Research Fund; Fondation du cancer du sein du Québec; Genome Canada; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; European Commission; Breast Cancer Research Foundation","keywords":"Aromatase inhibitor; Aromatase; Breast cancer; Oncology; Medicine; Internal medicine; Cancer; Gene; Bioinformatics; Cancer research; Biology; Genetics","score_opus":0.022577436593291242,"score_gpt":0.32725739991027936,"score_spread":0.3046799633169881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407752195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8538812,0.041700143,0.03797655,0.058815837,0.0011538294,0.00012964016,0.00092626363,0.00015938531,0.005257158],"genre_scores_gemma":[0.9701052,0.0075697326,0.011845967,0.007768074,0.0017246532,0.000081347716,0.00024921785,0.000064583,0.0005912562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9902686,0.0068666637,0.0006565229,0.0012925491,0.0007068613,0.00020882589],"domain_scores_gemma":[0.9485779,0.042377412,0.001341154,0.004764068,0.0021031653,0.00083641906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03361304,0.0009875845,0.0016109984,0.0012097538,0.00055027,0.001531431,0.0014837367,0.0012411755,0.0012730416],"category_scores_gemma":[0.053765792,0.00029144812,0.002097131,0.0013841565,0.002211477,0.0015594037,0.0013660254,0.0019567618,0.00020095166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004774451,0.0003979559,0.69029844,0.0010719313,0.008301152,0.0058459006,0.0021308553,0.004816867,0.012103536,0.01235818,0.008899082,0.24900168],"study_design_scores_gemma":[0.0020031817,0.00511727,0.8471271,0.0015536401,0.010436727,0.0058720415,0.0026481352,0.01612737,0.0056337337,0.07727671,0.025922975,0.000281201],"about_ca_topic_score_codex":0.0042896047,"about_ca_topic_score_gemma":0.0047552926,"teacher_disagreement_score":0.03361304,"about_ca_system_score_codex":0.00047816482,"about_ca_system_score_gemma":0.0013841605,"threshold_uncertainty_score":0.1777649},"labels":[],"label_agreement":null},{"id":"W4408279570","doi":"10.1038/s41523-025-00738-7","title":"Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Anthracycline; Medicine; Epirubicin; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Regimen; Chemotherapy; Cancer","score_opus":0.005124689768412764,"score_gpt":0.2407062181391821,"score_spread":0.23558152837076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408279570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969356,0.0018818094,0.00014088799,0.00013571697,0.000010716071,0.000009528918,0.00013909316,0.0000055124374,0.0007411061],"genre_scores_gemma":[0.99914145,0.0002244516,0.00008139936,0.000037630984,0.000025425828,0.000007102653,0.00017562018,0.0000023033795,0.00030467453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989827,0.00073608285,0.00004278901,0.00006700918,0.00009199662,0.00007931505],"domain_scores_gemma":[0.9971207,0.0014932656,0.0007052215,0.00028188812,0.00007839322,0.00032045203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019856535,0.00025639872,0.00053876895,0.0003111689,0.00012150237,0.0004999828,0.00021483652,0.00042824537,0.0017224845],"category_scores_gemma":[0.0038591232,0.00015371533,0.0010938628,0.0002758374,0.0002414134,0.00019040008,0.00023682778,0.00072592974,0.00013543332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040624768,0.00028886666,0.9165849,0.00014668873,0.002674689,0.00018973376,0.00006688007,0.0011989289,0.004215451,0.00025901722,0.0004798962,0.03327013],"study_design_scores_gemma":[0.00044953552,0.0024802415,0.9932052,0.000019219591,0.0010981621,0.00021103593,0.00003116909,0.0010457647,0.0006040163,0.00023409347,0.0006131029,0.000008550044],"about_ca_topic_score_codex":0.0008009619,"about_ca_topic_score_gemma":0.0019645146,"teacher_disagreement_score":0.0019856535,"about_ca_system_score_codex":0.00015806653,"about_ca_system_score_gemma":0.00026390224,"threshold_uncertainty_score":0.0105012655},"labels":[],"label_agreement":null},{"id":"W4409785972","doi":"10.1038/s41523-025-00754-7","title":"Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Memorial University of Newfoundland","funders":"","keywords":"Trastuzumab; Toxicity; Composition (language); Chemistry; Internal medicine; Medicine; Cancer; Breast cancer; Art","score_opus":0.007939468048927175,"score_gpt":0.29222461543254774,"score_spread":0.28428514738362054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908686,0.00033284537,0.00013604939,0.00005747858,0.0000035927574,0.0000043004516,0.000062280946,0.0000031764596,0.00031351772],"genre_scores_gemma":[0.99970835,0.00005678034,0.00006264192,0.000012636814,0.0000042544216,0.0000027891385,0.000052161296,9.408411e-7,0.000099339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978226,0.0000900869,0.000021282205,0.000026505992,0.000048032598,0.000031784446],"domain_scores_gemma":[0.999159,0.00027670895,0.0003850205,0.000026968784,0.000046706748,0.0001055632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005005102,0.00013823088,0.00020837424,0.00030885293,0.00010082738,0.00034331458,0.00008348919,0.00016741504,0.0009195033],"category_scores_gemma":[0.0020581284,0.000063378066,0.00019916432,0.00032479514,0.00013989756,0.0001556929,0.00023589276,0.0002977131,0.000098547855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004902923,0.00003400617,0.9917105,0.000007411727,0.000054287266,0.00004633872,0.00002759585,0.00024386568,0.0007919399,0.00001676807,0.000046013243,0.006531137],"study_design_scores_gemma":[0.000005203836,0.00017731452,0.99844897,0.0000038210005,0.000029731817,0.00016256778,0.000036165657,0.0006955598,0.00025997192,0.000031634507,0.00014701813,0.0000019864062],"about_ca_topic_score_codex":0.00089499116,"about_ca_topic_score_gemma":0.0013263071,"teacher_disagreement_score":0.0009195033,"about_ca_system_score_codex":0.00019236795,"about_ca_system_score_gemma":0.000144988,"threshold_uncertainty_score":0.003076017},"labels":[],"label_agreement":null},{"id":"W4410708732","doi":"10.1038/s41523-025-00759-2","title":"Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Single Center; Breast cancer; Medicine; Oncology; Internal medicine; Center (category theory); Cancer","score_opus":0.024748921851020744,"score_gpt":0.37959586164959996,"score_spread":0.35484693979857923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410708732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995566,0.00009230554,0.000043805823,0.00001181281,0.000001151803,0.0000040263067,0.0001620708,0.0000013570741,0.00012681934],"genre_scores_gemma":[0.9995752,0.000034713143,0.00003494945,0.000012927032,0.0000042686024,0.0000054039347,0.00028789145,0.0000016677886,0.000043020384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995371,0.00012382258,0.000060498838,0.00013449597,0.000071581664,0.00007247616],"domain_scores_gemma":[0.9987864,0.0002370802,0.0005599612,0.000090986316,0.00011286127,0.00021269757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046865674,0.00016863763,0.00042114832,0.00062110095,0.0003714005,0.00043503483,0.00026973672,0.0003101338,0.000996115],"category_scores_gemma":[0.0014702253,0.00024300916,0.00039265145,0.0010038414,0.0002389159,0.0003414822,0.00027146397,0.0002906606,0.00019751827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018504549,0.000028224504,0.9987809,0.0000034694044,0.00004466508,0.000060558723,0.000021997203,0.000052651623,0.00018858454,0.0000052040073,0.000043595355,0.0005851277],"study_design_scores_gemma":[0.000016836833,0.00019287928,0.99880564,0.0000025233471,0.00004008933,0.00040241747,0.00010817216,0.00020650975,0.00010610349,0.000011576543,0.000102562146,0.000004769148],"about_ca_topic_score_codex":0.003216339,"about_ca_topic_score_gemma":0.0038485737,"teacher_disagreement_score":0.003216339,"about_ca_system_score_codex":0.00042993407,"about_ca_system_score_gemma":0.00033649214,"threshold_uncertainty_score":0.0063952208},"labels":[],"label_agreement":null},{"id":"W4410850753","doi":"10.1038/s41523-025-00762-7","title":"A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study)","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa; Thunder Bay Regional Health Sciences Centre; Ottawa Hospital","funders":"Ottawa Hospital Foundation; Northern Ontario Academic Medicine Association; Ottawa Hospital Research Institute","keywords":"Evening; Morning; Randomized controlled trial; Dosing; Adjuvant; Medicine; Adjuvant therapy; Internal medicine; Cancer","score_opus":0.033985883043951066,"score_gpt":0.3307048067688537,"score_spread":0.29671892372490266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410850753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92027575,0.013144089,0.0029337686,0.0034151534,0.0028576422,0.046117943,0.0040635457,0.00029555729,0.0068965564],"genre_scores_gemma":[0.9200708,0.003782603,0.011663605,0.0044092266,0.001438198,0.050893538,0.0024115117,0.00006015602,0.005270133],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705935,0.00226849,0.00014655052,0.00024674862,0.00014817594,0.00013068551],"domain_scores_gemma":[0.997282,0.0009503872,0.00082991144,0.00018851769,0.00019120412,0.00055797223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051221224,0.0016109077,0.002923344,0.00042801845,0.0005534914,0.00096348167,0.0008477329,0.0017372064,0.0101955915],"category_scores_gemma":[0.0067281816,0.00061645964,0.0021594462,0.0005325051,0.0009889478,0.0009564233,0.00070734497,0.002304599,0.0008618396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9796484,0.004308157,0.0004075924,0.0013931439,0.0010625349,0.000042484415,0.000054847467,0.00015582106,0.0009505609,0.00026926468,0.001254555,0.010452596],"study_design_scores_gemma":[0.97005224,0.027720282,0.00075380766,0.00006435893,0.00036197106,0.000022667798,0.000019545168,0.00014214349,0.000064325184,0.00016046484,0.00062859646,0.000009784964],"about_ca_topic_score_codex":0.00095804484,"about_ca_topic_score_gemma":0.0023211131,"teacher_disagreement_score":0.0101955915,"about_ca_system_score_codex":0.0007984347,"about_ca_system_score_gemma":0.0017467279,"threshold_uncertainty_score":0.034107625},"labels":[],"label_agreement":null},{"id":"W4411308989","doi":"10.1038/s41523-025-00763-6","title":"Trends in contralateral breast cancer and contralateral prophylactic mastectomy from 2009 to 2016","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Canada; Cancer Care Ontario","keywords":"Mastectomy; Medicine; Breast cancer; Cancer; Prophylactic Mastectomy; Oncology; General surgery; Internal medicine","score_opus":0.005303011623725965,"score_gpt":0.2699333729662562,"score_spread":0.2646303613425302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411308989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80935967,0.008811136,0.00064556574,0.0026274102,0.00014795254,0.00012660856,0.15308557,0.00020873008,0.024987482],"genre_scores_gemma":[0.9481884,0.005278713,0.00067792786,0.00056851,0.000045764275,0.00006105148,0.035722647,0.000035404115,0.009421472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917954,0.000021493917,0.00006511973,0.00012125682,0.00038132432,0.00023121807],"domain_scores_gemma":[0.99790454,0.00006118746,0.0005324895,0.00004198832,0.0010380083,0.0004218325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031876142,0.00022785747,0.0003143975,0.0015575836,0.00082165666,0.0006233289,0.0008536316,0.00031937132,0.0038847295],"category_scores_gemma":[0.0018376277,0.00018894512,0.0005675737,0.0027864566,0.00032513594,0.00030646563,0.00054872,0.0005832512,0.0004356054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020396385,0.000023896977,0.9575627,0.00024014233,0.00010414256,0.000150132,0.00039655942,0.00034845833,0.00044398723,0.00043790118,0.018489681,0.021598384],"study_design_scores_gemma":[0.0000064049286,0.000020491863,0.9875488,0.000088135625,0.000040070874,0.00026073187,0.0004139251,0.00023216105,0.0001139039,0.00003400119,0.011228911,0.000012404361],"about_ca_topic_score_codex":0.97597957,"about_ca_topic_score_gemma":0.9894873,"teacher_disagreement_score":0.97597957,"about_ca_system_score_codex":0.016196663,"about_ca_system_score_gemma":0.02067071,"threshold_uncertainty_score":0.117515564},"labels":[],"label_agreement":null},{"id":"W4412166029","doi":"10.1038/s41523-025-00768-1","title":"Advancing equitable access to innovation in breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Agence Nationale de la Recherche; European Commission; Equipex; Health Research Board","keywords":"Breast cancer; Business; Oncology; Medicine; Cancer; Internal medicine","score_opus":0.19157179230998192,"score_gpt":0.46597159629673846,"score_spread":0.27439980398675656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412166029","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032577608,0.04043318,0.110633805,0.5079932,0.0023642199,0.00071786135,0.00028509874,0.00023088834,0.3047641],"genre_scores_gemma":[0.8995218,0.022382539,0.037014786,0.025627175,0.0027785634,0.0010591367,0.00012961353,0.0001553871,0.011330886],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.89181745,0.08581345,0.0027442765,0.0028871384,0.011184114,0.0055536344],"domain_scores_gemma":[0.7623374,0.19264689,0.010641309,0.013640186,0.01343116,0.0073030014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.116916224,0.0005224319,0.0011609658,0.0038201807,0.003016829,0.01523825,0.002293144,0.005987576,0.015279247],"category_scores_gemma":[0.22799239,0.00039791196,0.0009672942,0.0024135925,0.01539171,0.014010068,0.02618058,0.004576846,0.0011410698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063152394,0.00007890677,0.00236243,0.00062962814,0.000063312014,0.000092295275,0.0018495611,0.0033657998,0.000103865714,0.88729984,0.007625596,0.09646559],"study_design_scores_gemma":[0.000055057746,0.00010992585,0.0011795781,0.0013769533,0.0000259662,0.00009709289,0.0014166766,0.0018372952,0.0003446213,0.907659,0.08587616,0.00002172054],"about_ca_topic_score_codex":0.0012361682,"about_ca_topic_score_gemma":0.0016527065,"teacher_disagreement_score":0.116916224,"about_ca_system_score_codex":0.00896003,"about_ca_system_score_gemma":0.030518252,"threshold_uncertainty_score":0.6183195},"labels":[],"label_agreement":null},{"id":"W4412521196","doi":"10.1038/s41523-025-00783-2","title":"Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; St Mary's Hospital Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Oncology; Circulating tumor DNA; Endocrine system; Clearance; Clinical trial; Cancer; Breast cancer; Urology; Hormone","score_opus":0.006896806610269056,"score_gpt":0.26723096116695855,"score_spread":0.2603341545566895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412521196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957047,0.0015142149,0.0013358567,0.00015120201,0.000010846718,0.000028693688,0.0002508171,0.0000380981,0.00096556515],"genre_scores_gemma":[0.9984933,0.00023524987,0.00079821,0.00008545738,0.000011220445,0.000011932079,0.00013264759,0.0000033432812,0.00022863627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968064,0.000120357676,0.000022147586,0.000069499234,0.00007570058,0.000031656466],"domain_scores_gemma":[0.99952877,0.00016324832,0.00017418512,0.000028379238,0.000048709695,0.000056718785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047698055,0.00018257192,0.0003283635,0.00028183544,0.000145083,0.0004423726,0.00014159067,0.00022866382,0.00048312158],"category_scores_gemma":[0.0015267447,0.00008628841,0.00010528249,0.00033002716,0.00012522486,0.00021078676,0.00016230281,0.00027885602,0.0001356361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003300778,0.00018925502,0.8366869,0.00011232286,0.000106295454,0.0004306038,0.00028215433,0.0027733326,0.04543821,0.00015099032,0.00065376196,0.109875284],"study_design_scores_gemma":[0.000121317156,0.0029839422,0.9464479,0.00003506753,0.00014769472,0.0022981798,0.00023177327,0.007374458,0.035878684,0.00040304378,0.0040506274,0.000027331202],"about_ca_topic_score_codex":0.0010381558,"about_ca_topic_score_gemma":0.0020579179,"teacher_disagreement_score":0.0010381558,"about_ca_system_score_codex":0.00033992925,"about_ca_system_score_gemma":0.00023595913,"threshold_uncertainty_score":0.0025225878},"labels":[],"label_agreement":null},{"id":"W4412626262","doi":"10.1038/s41523-025-00796-x","title":"The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer","year":2025,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Office of Defense Programs; Cancer Research UK; National Institutes of Health; Royal Marsden NHS Foundation Trust; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; Immunotherapy; Hormone receptor; Hormone; Oncology; Cancer; Medicine; Internal medicine; Receptor; Cancer immunotherapy; Cancer research","score_opus":0.010740190256175721,"score_gpt":0.3146805826261346,"score_spread":0.30394039236995885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412626262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047693877,0.99906296,0.00004798019,0.00028856148,0.00013928168,0.0000017767721,0.0000069249363,0.0000027993365,0.0004020533],"genre_scores_gemma":[0.00045371073,0.9988104,0.00007436074,0.0002768663,0.00013472942,0.0000031926645,0.000010526558,8.194618e-7,0.00023535285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997054,0.00008120712,0.00003543034,0.000036364476,0.00011751668,0.000024077779],"domain_scores_gemma":[0.99948823,0.00034179408,0.000053827396,0.000013824361,0.00007857838,0.000023673541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007783896,0.0005390047,0.0012749885,0.0015692636,0.00021130372,0.0010015797,0.00064082094,0.0011927213,0.003133827],"category_scores_gemma":[0.0011012104,0.00018730688,0.000603735,0.0012651953,0.00046642392,0.0012496547,0.0006382807,0.002028774,0.0011804051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007348162,0.0000400699,0.00009111986,0.023830066,0.00014287452,0.00013148492,0.000049848295,0.0003878258,0.0011887149,0.0058909296,0.0240989,0.9440747],"study_design_scores_gemma":[0.000019101693,0.00010642532,0.0006586814,0.009546885,0.0001395594,0.0010223561,0.00005909474,0.00007786926,0.00027954753,0.0040005837,0.9840746,0.000015319074],"about_ca_topic_score_codex":0.00078535755,"about_ca_topic_score_gemma":0.0017778389,"teacher_disagreement_score":0.003133827,"about_ca_system_score_codex":0.00057453424,"about_ca_system_score_gemma":0.00097584823,"threshold_uncertainty_score":0.010483742},"labels":[],"label_agreement":null},{"id":"W4413803778","doi":"10.1038/s41523-025-00821-z","title":"Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University Health Network; Queen's University; University of British Columbia","funders":"Göteborgs Universitet; Canadian Cancer Society","keywords":"Radiation therapy; Node (physics); Medicine; Oncology; Internal medicine; Engineering","score_opus":0.017702037874718975,"score_gpt":0.2820940149337266,"score_spread":0.26439197705900763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413803778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797632,0.01630685,0.00027994104,0.0005571406,0.00015558806,0.00008435129,0.00061327737,0.000037475773,0.0022022363],"genre_scores_gemma":[0.9969092,0.0010104596,0.00018328968,0.00020744104,0.00019752074,0.00015086982,0.0005838254,0.0000072407624,0.0007500793],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992046,0.00055093574,0.0000322108,0.00008683341,0.000064898784,0.00006056159],"domain_scores_gemma":[0.9989116,0.00048785558,0.00031132932,0.00007809441,0.00004329011,0.00016782932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017040628,0.0005033274,0.0009676988,0.00018090059,0.00013109566,0.00071882433,0.00043613833,0.0005873585,0.0019438982],"category_scores_gemma":[0.0026359982,0.00014511912,0.00089522405,0.00027512456,0.00026916794,0.0004876486,0.00024734723,0.0010271447,0.00025075107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59806263,0.0017453455,0.17513998,0.0026436597,0.009331049,0.0003423924,0.00017367529,0.009632796,0.013394819,0.0010993918,0.011172589,0.1772617],"study_design_scores_gemma":[0.105956286,0.19085948,0.6286813,0.0010556917,0.017959965,0.0010685017,0.00022129473,0.02572001,0.005324599,0.0034837646,0.019487554,0.00018150352],"about_ca_topic_score_codex":0.00026758792,"about_ca_topic_score_gemma":0.00069339626,"teacher_disagreement_score":0.0019438982,"about_ca_system_score_codex":0.00028862653,"about_ca_system_score_gemma":0.00023658246,"threshold_uncertainty_score":0.009012103},"labels":[],"label_agreement":null},{"id":"W4414478250","doi":"10.1038/s41523-026-00955-8","title":"Multimodal analysis of a rare BARD1 missense variant suggests its pathogenicity is conditional","year":2025,"lang":"en","type":"preprint","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Faculty of Medicine and Health, University of Sydney; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Merck Canada; McGill University Health Centre; McGill University","keywords":"Missense mutation; Germline; Loss of heterozygosity; Proband; Breast cancer; Germline mutation; Heteroduplex; Tamoxifen","score_opus":0.009118949755469785,"score_gpt":0.27419742798817215,"score_spread":0.26507847823270236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414478250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029166,0.0010282862,0.002406125,0.00076782866,0.00007079278,0.000019869813,0.0007923786,0.00015531259,0.004467722],"genre_scores_gemma":[0.99817586,0.00014975906,0.000698479,0.00010539639,0.000023764642,0.0000032261937,0.00016509087,0.000018096382,0.000660298],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9998017,0.00001626075,0.000013581391,0.000076936776,0.000057577498,0.00003400641],"domain_scores_gemma":[0.99979144,0.00008748964,0.00005021205,0.000017159815,0.0000145186095,0.000039242776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009686374,0.00037384892,0.00023089517,0.0005176118,0.0002995906,0.00029937876,0.00026332142,0.0008715592,0.0028766927],"category_scores_gemma":[0.0006034965,0.00008649206,0.00024298392,0.0003231335,0.00040355383,0.00015495415,0.00027370107,0.0005076796,0.0005057438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071227277,0.000094465126,0.07732332,0.00015964739,0.00009209538,0.4549897,0.00039094576,0.00040876065,0.43471038,0.0015936674,0.001610708,0.027914014],"study_design_scores_gemma":[0.00003643929,0.00025541688,0.13014844,0.000051780058,0.00013492488,0.7048041,0.00030253993,0.0021577422,0.1496956,0.0014567095,0.010923659,0.000032682507],"about_ca_topic_score_codex":0.0007862235,"about_ca_topic_score_gemma":0.00072255026,"teacher_disagreement_score":0.0028766927,"about_ca_system_score_codex":0.0002340336,"about_ca_system_score_gemma":0.0001214616,"threshold_uncertainty_score":0.0096235275},"labels":[],"label_agreement":null},{"id":"W4414662508","doi":"10.1038/s41523-025-00820-0","title":"Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; NIHR Cambridge Biomedical Research Centre; Department of Health and Social Care; Medical Research Council; Universiti Malaya; Breast Cancer Research Foundation; National Research Foundation Singapore; Universiti Kebangsaan Malaysia; National Medical Research Council; National Research Foundation; Wellcome Trust; Cancer Research UK; Universiti Sains Malaysia; Government of Canada; AstraZeneca; Yayasan Sime Darby; Canadian Institutes of Health Research; Gray Foundation; National Institutes of Health; Kementerian Kesihatan Malaysia; Hospital Universiti Sains Malaysia; National Institute for Health and Care Research; Genome Canada; Fondation du cancer du sein du Québec; Ovarian Cancer Research Fund","keywords":"Polygenic risk score; Breast cancer; Confidence interval; Risk assessment; Population; Cancer; Lifetime risk; Risk factors for breast cancer","score_opus":0.005676353202433707,"score_gpt":0.2574515463959195,"score_spread":0.2517751931934858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414662508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567187,0.00021996415,0.0029764154,0.00007221724,0.000010018375,0.000018322804,0.00041807897,0.00003730626,0.00057587883],"genre_scores_gemma":[0.997675,0.00006795017,0.0017065982,0.000013697772,0.000008716254,0.0000094877705,0.00036785737,0.000007211868,0.00014360066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897504,0.000572752,0.00008467781,0.00017329253,0.00013188971,0.000062348845],"domain_scores_gemma":[0.9966857,0.0016668045,0.0008563923,0.0003239761,0.00023358503,0.00023355473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002978568,0.00064227893,0.0003693503,0.0014558668,0.00023717555,0.00060758175,0.00042608049,0.00032059097,0.0014012922],"category_scores_gemma":[0.0074474565,0.00016145801,0.0011508245,0.0011747315,0.00027040465,0.00035172567,0.0006860469,0.00059488096,0.00023247108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005576519,0.000048341197,0.9845077,0.000020020128,0.0005113242,0.00012570253,0.00009113259,0.001735303,0.0007293114,0.00013897981,0.0001996934,0.011334681],"study_design_scores_gemma":[0.000056658733,0.00059022417,0.9645342,0.000019542116,0.0006549552,0.0008497518,0.00017149381,0.030990576,0.0008657954,0.00066214055,0.0005750794,0.000029686384],"about_ca_topic_score_codex":0.0044713547,"about_ca_topic_score_gemma":0.003521944,"teacher_disagreement_score":0.0044713547,"about_ca_system_score_codex":0.00026050938,"about_ca_system_score_gemma":0.0003355713,"threshold_uncertainty_score":0.015752316},"labels":[],"label_agreement":null},{"id":"W4415619960","doi":"10.1038/s41523-025-00824-w","title":"A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Sault Area Hospital; Jewish General Hospital; University of Toronto; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache","funders":"National Institute for Health and Care Research; NIHR Bristol Biomedical Research Centre; Association of Breast Surgery; Department of Health and Social Care; Royal College of Surgeons of England; Breast Cancer Research Foundation","keywords":"Delphi method; Breast cancer; Outcome (game theory); Neoadjuvant therapy; Systemic therapy; Consistency (knowledge bases); Radiation therapy; Delphi","score_opus":0.5005127874530704,"score_gpt":0.5781129949305013,"score_spread":0.0776002074774309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619960","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1181966,0.0038196878,0.4877809,0.01226377,0.0019932615,0.3107986,0.024727218,0.0014569098,0.038963087],"genre_scores_gemma":[0.119415246,0.0007606396,0.36478886,0.0016866017,0.00023336113,0.49978754,0.012408476,0.00022012973,0.000699174],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.4697437,0.3447331,0.14566895,0.0038748232,0.031658113,0.0043212455],"domain_scores_gemma":[0.34712806,0.40083402,0.050316494,0.05474014,0.14081496,0.006166343],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.48802778,0.0017016869,0.0035976665,0.016270354,0.0037045695,0.0050583426,0.0032161921,0.002662456,0.006134466],"category_scores_gemma":[0.5410262,0.0011934692,0.008069507,0.01140581,0.0032567666,0.005220948,0.011948477,0.004513759,0.0017248121],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006949687,0.00153494,0.08070709,0.05076965,0.003910532,0.00053440314,0.02669869,0.014641738,0.005056892,0.0949989,0.082405835,0.6317916],"study_design_scores_gemma":[0.0077898228,0.009010188,0.28451458,0.05069302,0.0044860747,0.0014485543,0.01652456,0.05258213,0.022676457,0.14712739,0.40185088,0.0012963555],"about_ca_topic_score_codex":0.0023161054,"about_ca_topic_score_gemma":0.0026920636,"teacher_disagreement_score":0.5119722,"about_ca_system_score_codex":0.010019339,"about_ca_system_score_gemma":0.03134585,"threshold_uncertainty_score":0.6313529},"labels":[],"label_agreement":null},{"id":"W4417311889","doi":"10.1038/s41523-025-00874-0","title":"The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Breast cancer; Estrogen receptor; Circulating tumor cell; Fluorescence in situ hybridization; Estrogen; Stage (stratigraphy); Disease; Proportional hazards model; Adjuvant therapy","score_opus":0.00607237937998069,"score_gpt":0.2828771518055007,"score_spread":0.27680477242552004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417311889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911566,0.00088605034,0.008522913,0.00022454152,0.000008582555,0.000011475051,0.0006944383,0.0000895779,0.00044666702],"genre_scores_gemma":[0.9970855,0.00017852146,0.0016205574,0.000026482463,0.0000070734113,0.000007775226,0.00060346484,0.000006236153,0.0004643252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998771,0.000032779462,0.000005862233,0.000052205836,0.000017433948,0.000014632547],"domain_scores_gemma":[0.99970835,0.00017289823,0.000062694045,0.000020935366,0.000017799226,0.000017384324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047056147,0.00027275467,0.00027169884,0.00034092512,0.00012545983,0.0005584927,0.00026681295,0.00029371763,0.0005248049],"category_scores_gemma":[0.0011882676,0.00010592295,0.0002706987,0.0002704967,0.00017737098,0.00022099013,0.00017796288,0.00032230894,0.00011510392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006007578,0.00016057637,0.6333388,0.0001087253,0.00022954388,0.00037287708,0.000124492,0.26846683,0.016609544,0.0013448907,0.0014766777,0.077166274],"study_design_scores_gemma":[0.000028042987,0.00018116235,0.13239798,0.000015740834,0.0000968645,0.00033130354,0.0000444073,0.8592498,0.0041593215,0.0021505777,0.0013260776,0.000018714501],"about_ca_topic_score_codex":0.007147217,"about_ca_topic_score_gemma":0.014212615,"teacher_disagreement_score":0.007147217,"about_ca_system_score_codex":0.00048081714,"about_ca_system_score_gemma":0.00036045586,"threshold_uncertainty_score":0.014211237},"labels":[],"label_agreement":null},{"id":"W4417359648","doi":"10.1038/s41523-025-00871-3","title":"Author Correction: Advancing equitable access to innovation in breast cancer","year":2025,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; MEDLINE; Work (physics); Cancer","score_opus":0.015231374146467884,"score_gpt":0.33255533212520094,"score_spread":0.3173239579787331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417359648","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017839496,0.0010971467,0.0008926854,0.11183742,0.878397,0.000018146633,0.00066591083,0.00029541514,0.0066179284],"genre_scores_gemma":[0.022507489,0.0126418425,0.007846244,0.17093903,0.34054527,0.00016900884,0.0021267256,0.001967894,0.44125658],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924474,0.0010582427,0.00100794,0.0008914065,0.004063377,0.00053160486],"domain_scores_gemma":[0.9570606,0.0127903875,0.0016958946,0.0021639604,0.024788016,0.001501302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053165285,0.0015541124,0.001159465,0.0022452231,0.0034625875,0.0050104056,0.0025376978,0.0070207817,0.034945443],"category_scores_gemma":[0.075425506,0.0007359154,0.001012343,0.001964051,0.0027961086,0.0025142771,0.001794294,0.013519781,0.021906856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016344244,0.000002753424,0.000041805328,0.00005555493,0.0000054544475,0.0001464529,0.00003651636,0.000028548968,0.00003055639,0.0020796119,0.99320483,0.0043516043],"study_design_scores_gemma":[0.000017874925,0.000010544355,0.00029539072,0.00024244917,0.00001953653,0.0005394283,0.00009005867,0.00017387827,0.0003695805,0.0023918997,0.99582314,0.000026281],"about_ca_topic_score_codex":0.01486145,"about_ca_topic_score_gemma":0.02089929,"teacher_disagreement_score":0.034945443,"about_ca_system_score_codex":0.0045397286,"about_ca_system_score_gemma":0.008005686,"threshold_uncertainty_score":0.1169042},"labels":[],"label_agreement":null},{"id":"W7116399323","doi":"10.1038/s41523-025-00856-2","title":"Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Breast cancer; Clinical trial; Cancer; Central nervous system; Radiation therapy; Systemic therapy; Translational research","score_opus":0.028536240674687137,"score_gpt":0.33006321745542,"score_spread":0.30152697678073287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116399323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019265313,0.82250077,0.0032233908,0.16262141,0.0028835146,0.00010728289,0.00027407406,0.000055755918,0.0064073433],"genre_scores_gemma":[0.024487616,0.92806196,0.012130365,0.02626579,0.005429551,0.00034527335,0.0006880418,0.00002479827,0.002566593],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99872464,0.00061730633,0.00012297062,0.00013998263,0.00016857116,0.00022646681],"domain_scores_gemma":[0.9975835,0.001087855,0.00024380093,0.000057573052,0.0005840209,0.0004432509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042245933,0.00076642603,0.0012387914,0.0010883185,0.000787556,0.0031539344,0.0011908142,0.0028451355,0.006460866],"category_scores_gemma":[0.0054871067,0.00028964234,0.0010220989,0.0010145536,0.0010453974,0.0034818256,0.001656179,0.005018049,0.0016616454],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005498237,0.00035025296,0.0022676594,0.010295096,0.00021125542,0.0009126953,0.0004668518,0.0013065493,0.0018697598,0.045642734,0.12146447,0.8146629],"study_design_scores_gemma":[0.00042410562,0.0010426994,0.0043919343,0.018857004,0.00050240936,0.0027530405,0.00282823,0.0015312074,0.0015594374,0.07860659,0.88738316,0.000120122226],"about_ca_topic_score_codex":0.001996104,"about_ca_topic_score_gemma":0.0069431113,"teacher_disagreement_score":0.006460866,"about_ca_system_score_codex":0.0024983233,"about_ca_system_score_gemma":0.010472767,"threshold_uncertainty_score":0.022342086},"labels":[],"label_agreement":null}]}